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ABSTRACT
Diseases in marine animals are emerging at an increasing rate. Disease forecasting
enabled by virus surveillance presents a proactive solution for managing emerging diseases.
Broad viral surveys aid in disease forecasting by providing baseline data on viral diversity
associated with various hosts, including many that are not associated with disease. However,
these viruses can become pathogens due to expansion in host or geographic range, as well as
when changing conditions shift the balance between commensal viruses and the host immune
system. Therefore, it is extremely valuable to identify and characterize viruses present in many
different hosts in a variety of environments, regardless of whether the hosts are symptomatic or
not.
The lack of a universal gene shared by all viruses makes virus surveillance difficult,
because no single assay exists that can detect the enormous diversity of viruses. Viral
metagenomics circumvents this issue by purifying viral particles directly from host tissues and
sequencing the nucleic acids, allowing for virus identification. However, virus identification is
only the first step, which should ideally be followed by complete sequencing of the viral genome
to identify genes of interest and develop assays to reveal viral prevalence, tropism, ecology, and
pathogenicity. This dissertation focuses on the discovery of novel viruses in marine animals,
characterization of complete viral genomes, and the development of subsequent diagnostic
assays for further analysis of virus ecology.
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First, viral metagenomics was used to explore the viruses present in the healthy Weddell
seal (Leptonychotes weddellii) population in Antarctica, which led to the discovery of highly
prevalent small, circular single-stranded DNA (ssDNA) viruses. The lack of knowledge
regarding the viruses of Antarctic wildlife warrants this study to determine baseline viral
communities in healthy animals that can be used to survey changes over time. From the healthy
Weddell seals, viral metagenomics led to the discovery of 152 novel anellovirus genomes,
encompassing two anellovirus species. Characterizing these viruses is important for
understanding the prevalence and diversity of ssDNA viruses, which have only recently been
described in marine animals. Furthermore, since emerging diseases can be caused by changing
conditions affecting host susceptibility to a virus that was previously not related to disease
(opportunistic pathogen), having baseline data allows for quick identification of the pathogen.
In addition to determining baseline data, viral metagenomics can explore the role of
viruses in disease. A novel virus, Asterias forbesi-associated circular virus (AfaCV), was
discovered in the Atlantic sea star Asterias forbesi displaying symptoms of sea star wasting
disease (SSWD). AfaCV was the first circular replicase-encoding ssDNA (CRESS-DNA) virus
discovered in echinoderms, but it was only present in 10% of SSWD sea stars indicating it is not
involved in the development of the disease.
This dissertation also focuses on elucidating the role of two previously characterized
viruses, chelonid fibropapillomatosis-associated herpesvirus (CHHV5; Chelonid herpesvirus 5,
ChHV5) and Zalophus californianus anellovirus (ZcAV), in animal health. PCR amplicon
sequencing was used to obtain large portions of the 132 kb genome of ChHV5, the putative
etiological agent of the neoplastic sea turtle disease, fibropapillomatosis. Obtaining the genome
of ChHV5 from Florida green, Kemp’s ridley, and loggerhead sea turtles provides data for
iii

phylogenetic analysis across geographic locations and sea turtle species, as well as a reference
for designing downstream molecular assays to examine viral latency.
ZcAV was first described from the lungs of captive sea lions involved in a mortality
event. PCR could not detect ZcAV in the blood of infected animals, and since sea lions are a
protected species, it is not possible to obtain lung biopsies from live sea lions to determine ZcAV
prevalence or its role in sea lion health. To answer these important questions, an enzyme-linked
immunosorbent assay (ELISA) was developed to detect antibodies to ZcAV in serum from wild
sea lion populations. This newly developed ELISA showed that sea lions mount an immune
response to ZcAV, and was used to determine the prevalence of ZcAV among wild sea lion
populations.
This dissertation makes an important contribution to marine science through discovery
and characterization of viruses present in healthy and diseased marine animals. Several different
methods were used for virus whole-genome sequencing including viral metagenomics, PCR
amplicon sequencing, and target enrichment. These findings were expanded upon by developing
and using PCR assays and a serological assay to screen for virus prevalence. These methods
have implications for viral surveillance and understanding the role of novel viruses in animal
health.
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CHAPTER ONE:
Introduction
Viruses are intracellular parasites capable of causing disease in humans, animals, and
plants. Viral epidemics are typically the result of a newly emerged virus, a jump from one
species to the next, or the re-emergence of a virus and its expansion to a new area (Morse 1991,
Brown 2004). While the genetic plasticity of viruses is a major factor in disease emergence, the
propensity for the virus to cause an epidemic lies in the delicate balance between host, pathogen,
and the environment. Environmental conditions such as population density, climate, and water
quality are all factors that contribute to pathogen transmission. Consequently, environmental
degradation can impart stressors on a population, leaving it susceptible to disease (Harb et al.
1993, Appawu et al. 2001, Patz et al. 2005).
Diseases are emerging at an increasing rate, and many are a direct result of environmental
changes (Harvell et al. 1999, Dobson and Foufopoulos 2001, Lederberg et al. 2003, Wilcox and
Gubler 2005). Human pathogens include viruses, bacteria, protozoa, fungi, and helminths, with
viruses representing the majority (44%) of emerging pathogens (Fig. 1) (Taylor et al. 2001).
Although virus research has largely been anthropocentric, human disease is inextricably linked to
animal health and therefore understanding disease in wildlife is an important component in
understanding disease emergence in humans. In fact, about 75% of emerging human pathogens
are zoonotic, meaning they are passed from animals to humans, with forty-one percent of the
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emerging zoonotic diseases caused by viruses (Fig. 1). This underscores the significance of
animals as viral reservoirs.
Although zoonotic events are an important reason for surveying animal viruses, instances
of viruses being passed from humans to animals (reverse zoonosis) are increasing and should not
be ignored (Dobson and Foufopoulos 2001, Messenger et al. 2014). Humans impact the
outcome of wildlife disease especially through environmental degradation and the disease itself
can become a driver of ecosystem changes as the balance between trophic levels is altered
(Epstein et al. 2003). Evaluating ecosystem health through sentinel species can provide insight
into animal health at a population level, as well as human and environmental health (Bossart
2006).
Surveying viruses in wildlife populations is important for disease forecasting, and
exploring viruses in the marine realm is no exception; with over half of the population living
near coastlines, human impact on marine life is significant. However, the knowledge of marine
animal viruses is largely limited to those that affect fisheries and aquaculture, and those that
cause mass mortality events. Significantly less is known about modes of virus transmission and
virus reservoirs. Unfortunately, marine diseases are especially difficult to contain due to the lack
of management techniques that are effective for the prevention and containment of terrestrial
diseases, such as vaccines and quarantining diseased individuals (McCallum et al. 2004).
Complex life cycles and migration patterns of marine animals combined with the general lack of
understanding of virus transmission processes makes it difficult to contain disease upon
detection. Once a disease becomes an epidemic, it can be detrimental to ecosystem community
structures by disrupting trophic interactions, resulting in further environmental decay (Epstein et
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al. 2003). Therefore, rapid detection of emerging disease through viral surveillance is imperative
for implementing management techniques to control virus spread in the marine environment.
Viral surveillance is not without obstacles, especially when the intention is to identify
emerging viruses. Unlike bacteria, viruses do not contain universal gene markers that can be
amplified and sequenced for identification. Current diagnostic methods, such as polymerase
chain reaction (PCR), microarray, and serology, are lacking in that they can only detect known
viruses and their close relatives (Wang et al. 2002, Symonds et al. 2009). Transmission electron
microscopy (TEM) is also used to identify the presence of viruses, but many viruses are
indistinguishable based on appearance, or undetectable by TEM. There are roughly 2.2 million
animal species in the ocean (Mora et al. 2011), with each species potentially harboring multiple
viruses, suggesting there is a wealth of viral diversity that these traditional methods cannot
efficiently detect. However, viral metagenomics circumvents these problems and has emerged as
an effective method for describing novel viruses (Edwards and Rohwer 2005, Delwart 2007).
Viral metagenomics (sequencing the nucleic acids of purified viral particles) was originally used
to describe uncultured viruses in the marine environment by virus purification followed by
shotgun sequencing (Breitbart et al. 2002). Viral metagenomics has since been used to explore
viruses of mucus, blood, feces, cell culture and tissue samples from animals, plants, and insects
(Ng et al. 2009, Svraka et al. 2010, Ng et al. 2011, Ng et al. 2011, Rosario and Breitbart 2011).
Originally, Sanger sequencing was used, but advances in sequencing technology has led the field
to move towards the use of next-generation (NGS) sequencing, including 454 pyrosequencing,
Illumina (appendices 1, 2, and 3), and PacBio (Appendix 3).
Despite the advances in virus discovery due to metagenomics and NGS technology,
determining the etiological agent of disease by fulfilling Koch’s postulates is an onerous and
3

oftentimes impossible task (Fredricks and Relman 1996). Koch’s postulates state (i) the
pathogen occurs in every case of disease, (ii) the pathogen can be isolated from the host and
grown in culture, (iii) a healthy host inoculated with the pathogen from pure culture induces the
disease, (iv) the same pathogen can be isolated from the newly infected host (Koch and Saure
1890). However, there are often factors that confound etiology of infectious disease, including
differences in disease manifestation based on genetic susceptibility, environmental conditions,
coinfections that can increase pathogenicity, and temporal delays between exposure and disease
(Evans 1976). Viruses that are unculturable, associated with chronic illnesses or multifactor
diseases, and those that infect protected species that cannot be experimentally infected must be
classified as causative agents through other methods. Viruses have been implicated as the
causative agent of neoplasms such as the Epstein-Barr virus in Burkitt’s lymphoma, and human
papillomavirus genotype 16 in cervical cancer using methods such as seroepidemiology, gene
expression or viral replicative form analysis, and presence of intact viral particles and viral
genome in affected tissues (Zur Hausen et al. 1970, Evans 1976, Fredricks and Relman 1996,
Walboomers et al. 1999).
Fortunately, the generation of genomic sequences is beneficial for the creation of
downstream diagnostic assays for specific viruses. Demonstrating an adaptive immune response
that is specific to the virus, proving of viral replication, measuring viral titers, and performing
epidemiology studies are necessary to infer disease causality (Lipkin 2010). With the
development of downstream applications in mind, characterizing whole genomes instead of
focusing on specific genes is necessary for understanding the ecological importance of the virus
(Houldcroft et al. 2016). Whole genome sequencing (WGS) can be used to track virus outbreaks
when certain marker genes with low genetic variability are not useful for transmission studies;
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for example, transmission of the recent outbreak of the Ebola virus was tracked using WGS
(Quick et al. 2016).
Currently, the three most common NGS approaches used for WGS of viruses are viral
metagenomics, PCR amplicon sequencing, and target enrichment (Houldcroft et al. 2017). It
should be noted that there are numerous techniques used for WGS including single virus
genomics, the assembly of RNA viruses through transcriptomics, the assembly of virus-derived
small silencing RNAs, and dsRNA isolation followed by NGS (Wu et al. 2010, Allen et al. 2011,
Shi et al. 2016, Urayama et al. 2016); however, this dissertation will focus on viral
metagenomics, amplicon sequencing, and target enrichment. While viral metagenomic
approaches are useful for the identification of novel viruses and characterization of viral
diversity, target enrichment sequencing and PCR amplicon sequencing are effective methods for
characterizing genomes of known viruses or their close relatives. PCR amplicon sequencing,
using complimentary primers to a known sequence, is the most common approach for
sequencing small viral genomes such as norovirus (Cotten et al. 2014), but this method can
become labor intensive when amplifying larger genomes. Larger genomes require more PCR
primers which involves optimizing each PCR assay and results in the need for large sample
amounts, which may be a limiting factor (Renzette et al. 2011). PCR amplicon sequencing has
been more successful for WGS than metagenomics when virus concentrations are low, although
target enrichment may be a more efficient method if the genome is large (Thomson et al. 2016).
Target enrichment is used to sequence genomes directly from samples without the need
for virus amplification using PCR or culturing prior to the enrichment, thus providing sequences
with fewer mutations than in amplified templates (Depledge et al. 2014, Tsangaras et al. 2014,
Wylie et al. 2015). The success of target enrichment sequencing is directly related to the
5

availability of a suitable reference genome of the target virus from which capture probes can be
designed. A higher number of reference genomes will result in an efficient capture of target
sequences because the specificity of the probes increases when they are designed against a panel
of reference genomes that can capture genetic diversity.
Once the viral genome is completed, it can be used for the creation of downstream assays
to determine the role of the virus in animal health. One of the first steps in elucidating the effects
of a virus on animal health is to determine its prevalence among healthy and diseased animals
and determine its tropism. To screen for prevalence, newly developed assays based on the
genomic information such as PCR are useful and cost effective, but not always feasible. In cases
where the animal is an endangered or protected species, tissue samples are difficult to obtain and
if the virus does not circulate in the blood, serological assays are useful to test for exposure to the
virus. In addition, serological assays provide valuable information about the adaptive immune
response of the host and therefore clues about virus-host interactions.
Broad viral surveys are critical for characterizing pathogens and baseline viral
communities. Environmental impacts have contributed to complex, multifactor diseases and the
rise of opportunistic pathogens (Lee Miller et al. 2001, Bossart et al. 2002, King et al. 2002,
Ylitalo et al. 2005). Therefore, establishing baseline data is necessary for forecasting emerging
diseases and understanding virus-host dynamics. Reducing the time between a disease outbreak
and detection of the responsible virus will impact the outcome for disease management and
containment.
This dissertation focuses on the discovery of novel viruses in marine animals,
characterization of complete viral genomes, and the development of diagnostic assays to
determine the ecological role of these viruses.
6

•

Diverse and highly recombinant anelloviruses associated with Weddell seals in
Antarctica (Appendix 1). The viruses circulating among Antarctic wildlife remain
largely unknown. In an effort to identify viruses associated with Weddell seals
(Leptonychotes weddellii) inhabiting the Ross sea, vaginal and nasal swabs and fecal
samples were collected for metagenomic analysis. In addition, a Weddell seal kidney
and South Polar skua feces were collected. Based on Illumina sequencing results,
abutting primers were designed and used for the recovery of 152 novel anellovirus
genomes that share 63-70% genome-wide identities with other pinniped anelloviruses.
Phylogenetic analysis revealed two anellovirus species, torque teno Leptonychotes
weddellii virus (TTLwV) -1 and -2. TTLwV-1 is highly recombinant and subdivided
into 40 genotypes. TTLwV-2 is subdivided into three genotypes and is much less
recombinant, with only 26% of the sequences having recombination events, compared to
the 89% of TTLwV-1 sequences. TTLwV is diverse and ubiquitous among Weddell
seals with multiple genotypes infecting individuals, but the role these viruses play in seal
health remains unknown.

•

Discovery of a novel circular DNA virus in the forbes sea star, Asterias forbesi
(Appendix 2). Sea stars are keystone predators in the marine environment, essential for
structuring intertidal invertebrate communities that are critical for ecosystem health. An
ongoing massive sea star die off in both the Atlantic and Pacific oceans is due to sea star
wasting disease (SSWD). Symptoms include white lesions on the epidermis, deflation,
and eventual death of the sea star. Although the disease is decimating the populations of
multiple species of sea stars, the etiological agent causing this disease was unknown at
the time of this study. This study explored the role of viruses in SSWD in Asterias
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forbesi from the Atlantic. Viral metagenomic analysis (virus purification followed by
Illumina DNA sequencing) was used to identify a single-stranded DNA (ssDNA) virus,
Asterias forbesi-associated circular virus (AfaCV). The AfaCV genome organization is
typical of circular Rep-encoding ssDNA (CRESS-DNA) viruses belonging to the
Circoviridae family. PCR-based assays designed to amplify the newly characterized
genome detected AfaCV in approximately 10% of Asterias forbesi with SSWD,
demonstrating the lack of a clear association between this virus and the disease.
However, AfaCV represents the first CRESS-DNA virus detected in echinoderms, adding
to the growing diversity of these viruses recently recovered from invertebrates.
•

Sequencing of the chelonid fibropapillomatosis-associated herpesvirus genome from
three Florida sea turtle species (Appendix 3). Fibropapillomatosis (FP) is a debilitating
disease of panzootic proportions that has been documented in all hard-shelled sea turtles,
but primarily affects green sea turtles (Chelonia mydas) (Barragan and Sarti 1994, Herbst
1994, Lackovich et al. 1999, Herbst et al. 2004, Ene et al. 2005, Williams and BunkleyWilliams 2006, Work et al. 2009, Alfaro-Núñez and Gilbert 2014). FP is the most
significant neoplastic disease in reptiles due to its rapid increase in prevalence and
geographic distribution (Herbst 1994). FP was first discovered in the late 1930's by
Smith and Coates (1938) in a Florida green turtle and has since spread worldwide with a
circumtropical distribution (Aguirre and Lutz 2004). Despite the large proportion of sea
turtles afflicted with FP, the etiological agent remains unconfirmed. However, there is
overwhelming evidence suggesting the disease is caused by a virus, now known as the
chelonid fibropapillomatosis-associated herpesvirus (CHHV5). Unfortunately, all
attempts to culture this virus, a precursor needed to fulfill Koch's postulates (Koch and
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Saure 1890), have failed, hindering efforts to understand the role of ChHV5 in FP.
Currently, the only genome available of ChHV5 was sequenced from the glottis tumor of
a Hawaiian green sea turtle using the bacterial artificial clone (BAC) system (Ackermann
et al. 2012). To sequence ChHV5 from tumors of Florida green, loggerhead, and Kemp’s
ridley sea turtles, the Hawaiian genome has been used as a scaffold for long-range PCR
followed by Illumina sequencing of amplicons; however, long regions of repeat sections
(>10 kb) have impeded genome completion. To obtain the repeat sections of the genome,
SureSelect Target enrichment is currently being used to enrich for the herpesvirus and
PacBio technology was used to obtain long sequence reads from the genome.
•

Development of a serological assay for the novel sea lion (Zalophus californias)
anellovirus, ZcAV (Appendix 4). In response to a mortality event of several captive
California sea lions (Zalophus californianus), viral metagenomics was previously used to
identify a novel anellovirus (ZcAV), which was subsequently determined to actively
replicate in the lungs of 100% of the sea lions that died in the mortality event (Ng et al.
2009). The identification of the virus is an important first step, but subsequent studies are
needed to determine the role of the virus in the disease. Sea lions are a protected species;
thus, it is not possible to obtain lung samples from live sea lions. Furthermore, ZcAV was
never detected in the blood of infected animals, and as a result, blood samples from live
sea lions could not be screened for ZcAV. This study developed an enzyme-linked
immunosorbent assay (ELISA) for the detection of antibodies to ZcAV in sea lion serum.
The ELISA was created based on regions predicted to be immunogenic in the putative
capsid protein of ZcAV. Ninety-six paired lung and serum samples were tested for
ZcAV using PCR and ELISA tested, respectively. 48% of samples were both ELISA and
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PCR negative, 11% were positive for both ELISA and PCR, 18% were PCR positive, but
ELISA negative, and 23% were PCR negative, but ELISA positive. These results
indicate that using an ELISA along with PCR provides robust results of ZcAV
prevalence.

Figure 1. The breakdown (by %) of emerging and zoonotic pathogens. 41% of viruses are
the etiological agent of emerging zoonotic disease.
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CHAPTER 2:
Discussion
Traditional laboratory methods used to detect viruses, including both molecular and
immunological assays, rely on previous knowledge of the sequence or antigenic properties of the
virus of interest. While these techniques are useful for the detection of known viruses and their
close relatives, they remain ineffective for the detection of genetically divergent viruses,
rendering them inefficient for viral surveillance (Wang et al. 2002, Symonds et al. 2009). The
relatively new method of viral metagenomics is a sequence-independent tool that circumvents
the issues associated with traditional laboratory techniques. However, technical and ethical
complications often arise when trying to link virus to disease. The coupling of traditional
diagnostic tools with metagenomics is imperative for uncovering the role of viruses in health.
This dissertation explores viruses of marine animals and moves beyond viral discovery by
developing subsequent diagnostic methods.
The lack of long-term disease surveillance in Antarctica has left many questions about
disease risk and prevalence. Moreover, it is unknown if Antarctic wildlife harbor unique
microbes because of the extreme climate and geographic isolation. Viral metagenomics analysis
of Weddell seals (Leptonychotes weddellii) revealed the presence of anelloviruses, which are
small, single-stranded DNA viruses (Appendix 1). Multiple PCR assays were designed using
these sequences, resulting in the discovery of 152 anellovirus genomes encompassing two
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species, TTLwV-1 and TTLwV-2. Exploring the viruses associated with Weddell seals is a step
towards establishing baseline data that can monitored for changes over time.
The TTLwVs were ubiquitous among the apparently healthy Weddell seal population.
This is not unusual as anelloviruses have been found in up to 100% of human populations
(Ninomiya et al. 2008), with multiple genotypes co-occurring in the body without evidence of
specific tropism. While they have been incidentally associated with many diseases, no direct
causal evidence exists between TTV and a specific disease (Okamoto 2009, Spandole et al.
2015). However, despite the lack of correlation between anelloviruses and any specific disease,
they are indicative of immune system health in humans by acting as a biomarker for immune
suppression, with high titers of TTVs indicating immunosuppression (Eloit et al. 2015). It is not
known if this correlation is true for Weddell seals or other marine mammals in which
anelloviruses have been described. Since Weddell seals have relatively naïve immune systems,
it would be interesting for future studies to explore the potential link between immune system
strength to anellovirus quantity in this species (Yochem et al. 2009).
Virus research has typically focused on pathogens, but recent advances in virus discovery
have introduced the emerging paradigm that viromes are more than a collection of pathogens and
that viruses not correlated with disease may still have implications for health. Original studies of
the microbiome were limited to bacteria and the symbiosis between microbe and host, but recent
studies have indicated the virome ranges from pathogens, to innocuous viruses that may be
harmful in a small fraction of the population, to commensal and even symbiotic viruses (Griffiths
1999, Bernardin et al. 2010, Haynes and Rohwer 2011, Virgin 2014, Cadwell 2015, Moustafa et
al. 2017). For example, it has been shown that certain eukaryotic viruses in the human
gastrointestinal tract may have parallel functions to beneficial bacteria living there (Kernbauer et
12

al. 2014, Cadwell 2015). Eukaryotic viruses have the capacity to support intestinal homeostasis
and shape mucosal linings (Kernbauer et al. 2014), therefore the potential contribution of viruses
to health should not be ignored, even if there is no apparent disease association.
Metagenomics is also a powerful tool for exploring viruses associated with disease, with
the caveat that the presence of a virus does not necessarily mean it is associated with disease.
From the leg of a sea star displaying symptoms of SSWD, a novel circular virus, Asterias
forbesi-associated circular virus (AfaCV), was discovered using viral metagenomics (Appendix
2). The genome organization is typical of a circular rep-encoding ssDNA (CRESS-DNA) virus,
but it is a genetically divergent virus from previously characterized genomes. Although AfaCV
is not associated with SSWD, this was the first CRESS-DNA virus discovered in echinoderms,
and is therefore an important discovery. Since then, CRESS-DNA viruses have been discovered
in other echinoderms including the green sea urchin (Strongylocentrotus droebachiensis) and
giant California sea cucumber (Parastichopus californicus) (Jackson et al. 2016). Metagenomic
studies reveal that CRESS-DNA viruses may be more prevalent in marine systems than
originally thought (Rosario et al. 2012, Rosario et al. 2015). Although AfaCV was not involved
in the development of SSWD, a metagenomics study investigating SSWD in asteroids from the
Northeast Pacific Ocean implicated a densovirus (sea star-associated densovirus; SSaDV) as the
most likely cause of SSWD in the region (Hewson et al. 2014).
Viral metagenomics is a critical first step in disease surveillance, as identification of a
viral sequence allows the virus to be further investigated with diagnostic tests such as PCR, in
situ hybridization, serology, and analysis of replication. For example, AfaCV was originally
identified in a sea star displaying symptoms of SSWD, but when a PCR assay was designed to
screen for prevalence, it was only found in 10% of samples, indicating it is not associated with
13

the disease, despite its initial disease-related discovery. PCR was used to explore SSaDV in
SSWD in East coast Forbes sea star. Twenty three of the 48 samples (48%) were positive for
SSaDV; however, this may be an underestimation of true SSaDV prevalence due the use of
standard PCR, which is less sensitive than quantitative PCR using an internal TaqMan probe.
Nevertheless, SSaDV appears to be associated with SSWD in Atlantic Forbes sea stars, similar to
the findings of Hewson et al. (2014) in the Pacific.
Unfortunately, viral metagenomic sequencing is not an effective method for capturing all
viruses, including ChHV5 (Appendix 3). To limit host nucleic acids from tissue samples for
sequencing viral nucleic acids, a combination of filtering, chloroform and nuclease treatment is
used (Ng et al. 2009, Ng et al. 2009). For enveloped viruses such as ChHV5, chloroform will
destroy the enveloped membrane, possibly rendering the viral DNA susceptible to nuclease
treatment (Allander et al. 2001). It is hypothesized that ChHV5 is in the episomal form (AlfaroNúñez and Gilbert 2014, Work et al. 2014), which would also be destroyed during the nuclease
step. PCR amplicon enrichment and target enrichment followed by next-generation sequencing
are effective, sequence-dependent methods useful for the recovery of viral genomes from
directly from tissue, without the requirement of culturing (Cotten et al. 2014, Depledge et al.
2014, Tsangaras et al. 2014, Gardy et al. 2015, Wylie et al. 2015, Quick et al. 2016). Using
primers based on a reference ChHV5 genome sequenced from the glottis tumor of a Hawaiian
green sea turtle using BAC cloning (Ackermann et al. 2012), long-range PCR followed by
Illumina sequencing of amplicons was used to sequence the ChHV5 genomes from several
species of Florida sea turtles. Since the disease manifests differently between Hawaii and
Florida it was important to determine if genetic differences of the virus contributed to those
differences.
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Generally, whole genomes are not obtained through metagenomic sequencing. Whole
genome sequencing (WGS) is necessary both for novel and previously described viruses.
Through WGS, molecular epidemiology, evolutionary genomics, and the identification of
interesting genes and recombination events is more effective (Houldcroft et al. 2017). This
dissertation highlights the importance of WGS through the development of back-to-back primers
based on metagenomic sequences, which led to the discovery of two anellovirus species
encompassing 43 genotypes associated with Weddell seals. This diversity of the TTLwVs would
not have been captured if the genomes were not sequenced.
It is necessary to pair WGS methods with traditional diagnostic methods to elucidate the
role of the virus in disease, but this can often pose ethical and technical challenges, especially
when the virus is unculturable. Obtaining tissue samples from wildlife is difficult, especially if
the species is protected. Creating serology-based assays is an option to screen live animals for
exposure to the virus and to determine whether the animal is mounting an immune response to
the virus. The ELISA developed to test for ZcAV exposure is an example of how a newly
discovered virus is a jumping off point for creating new diagnostic assays (Appendix 4). ZcAV
was originally found in a protected species and was not detectable in the blood. Since there was
no way to screen for ZcAV in live sea lions, an ELISA was developed to screen for antibodies to
ZcAV. Furthermore, ZcAV was identified from a mixed community of viruses and has not been
. This ELISA provides a way to screen for exposure to this virus for prevalence and
epidemiological studies. Since many newly discovered viruses are unculturable and/or have
difficulties associated with sampling the host, moving toward developing an ELISA is one step
towards linking virus to disease. Developing an ELISA using synthesized peptides predicted
from next-generation sequencing data is currently used for exploring plant viruses, but as more

15

unculturable viruses are discovered, this may become more common for animal virus (Boonham
et al. 2014).
This dissertation explores the strengths and limitation of viral metagenomics for
characterizing viruses and their role in health. Viral metagenomics identified sequences of novel
viruses (appendices 1 and 2) and expanded the known host range of CRESS-DNA viruses. This
method is useful for recovering viruses from healthy and diseased animals, but is limited in its
ability to elucidate virus-host interactions. Therefore, traditional diagnostic tools developed from
the genetic information obtained through metagenomics are required to examine the link between
virus and host (Appendix 4). Another limitation is the ability to detect all viruses (Appendix 3).
Viruses at low copy numbers, and those in the latent stage, cannot be purified using typical virus
isolation methods, and consequently will not be detected. Although attempted, ChHV5 was not
recovered using viral metagenomic techniques. Therefore, other WGS methods are being used
to complete the genome.
The appropriate WGS technique should be determined based on whether a targeted or a
non-targeted approach is needed to achieve the goal of the study. Metagenomics is most
efficiently used as a non-targeted approach. If metagenomics is used while looking for a specific
virus, generally very few reads are recovered from the target virus. For example, metagenomic
analysis resulted in only 0.008% EBV reads in the blood of a healthy adult (Allen et al. 2016).
Samples can be enriched for viruses, which increases read coverage and proportion, but the
proportion of reads are still relatively low when compared to the amount of host-derived
sequences (Matranga et al. 2014, Calvet et al. 2016). The advantage of metagenomics is that it is
effective for identifying viral diversity and emerging viruses. If a specific virus is being
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investigated, then a targeted approach like PCR amplicon sequencing or target enrichment may
be effective (Thomson et al. 2016).
In the past, diseases caused significant mortality or morbidity before the etiological was
discovered. The metagenomic approach provides the potential for proactive pathogen
surveillance, instead of a reactive approach that is typically used during an epidemic. Benefits of
virus surveillance include (i) identifying genetic clues that explain the jump of a virus from one
host to the next, (ii) understanding drivers of disease emergence by tracking virus diversity and
evolution during land-use changes, (iii) deciphering genetic changes that increase virulence, and
(iv) providing time for the development of vaccines.
No disease has been successfully predicted before its outbreak in humans, which is
partially due to the lack of knowledge of viral diversity in wildlife (Jones et al. 2008, Morse et al.
2012). Assessing the viromes associated with animals that frequently carry zoonotic viruses
such as bats, rodents, blood-sucking arthropods, and animals that come in close contact with
humans or are consumed by humans is one way to increase surveillance efficiency. Another way
to increase the efficiency of disease forecasting is to focus on the interface between wildlife and
humans. Detecting a pathogen before the human encroachment of wildlife, allows management
to take prophylactic measures against disease outbreak. Vector-enabled metagenomics, the
targeting of disease vectors for metagenomic analysis, is productive for characterizing viromes
within an ecosystem (Ng et al. 2011, Brinkmann et al. 2016). PCR assays can be subsequently
used to target specific viruses of interest and identify their hosts.
Understudied ecosystems and the animals that inhabit them should not be ignored.
Although zoonotic events are often short term, it is not known where many well-established
human viruses originated. Many animals in the marine environment remain unexplored, despite
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the increase in disease emergence and significant mortality events that occasionally follow
(Harvell et al. 1999, Gulland and Hall 2007, Anthony et al. 2012, Hewson et al. 2014). As more
viruses are being characterized from the marine environment, the link between terrestrial and
marine disease is becoming evident. The viral disease distemper and caliciviruses can move
between marine and terrestrial environments (Smith et al. 1998, Philippa et al. 2004). A novel
picornavirus recently discovered in seals is related to human hepatitis A (Anthony et al. 2015),
indicating that well established viruses in humans may originate from the ocean. Viruses of
terrestrial animals may have originated from the marine environment and therefore marine
animals should not be ignored as a reservoir of potential emerging diseases.
Advances in sequencing technology have led to an influx of newly identified viruses
(Massart et al. 2017, Moustafa et al. 2017), with the overwhelming majority of them lacking a
culture system (Fredricks and Relman 1996). This has led to proposed revisions of Koch’s
postulates to better suit viruses and technological advances (Rivers 1937, Falkow 1988,
Fredricks and Relman 1996, Mokili et al. 2012). While Koch’s postulates remain the gold
standard for determining etiology, molecular-based methods have been used to bypass fulfilling
the postulates. Merkel cell polyomavirus (MCV), human papillomavirus (HPV), and human
immunodeficiency virus (HIV) were identified as the causative agents of Merkel’s cell
carcinoma, cervical cancer, AIDS, respectively, without satisfying Koch’s postulates
(Montagnier et al. 1987, Walboomers et al. 1999, Feng et al. 2008).
Metagenomic studies are limited by the ability for taxonomic identification of sequences
based on comparisons against public databases using similarity-based searches, such as BLAST
(Altschul et al. 1990, Huson et al. 2007). Unfortunately, most sequences obtained through viral
metagenomics have no sequence homology to any sequences in the database, which is
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incomplete and does not represent total viral diversity (Edwards and Rohwer 2005, McHardy et
al. 2007). In cases where similarity-based sequence identification fails, composition-based
identification methods are used based on GC content and tetranucleotide signatures (Teeling et
al. 2004). Composition-based identification has mostly been used for identifying bacteria, but it
remains a promising area for viral identification (Fancello et al. 2012). In silico advancements
are needed to identify unknown reads as viruses, thus contributing to a more robust database of
viral sequences. Quick identification of emerging viruses and their hosts will result in a rapid
response to enhance the safety of public health. This dissertation describes three new viruses
that are now in the NCBI database to aid with viral identification in future studies.
Viral metagenomics is a salient technology that will enhance the understanding of viral
diversity, transmission, and emergence. By continuing to describe viruses from healthy and
diseased animals, the role of viruses in animal health will become apparent and contribute to the
paradigm shift from “all viruses are pathogens” to the idea of a normal, healthy virome. As virus
discovery continues, research needs to move towards a holistic approach. The outcome of viral
infection is largely due to context, meaning that host genotype, coinfections, presence of
commensal bacteria, and environmental factors all contribute to the phenotypic outcome of the
virus. As viral diversity and dynamics are better characterized, disease prediction and
forecasting should eventually be possible (Anthony et al. 2015).
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Abstract
The viruses circulating among Antarctic wildlife remain largely unknown. In an effort to identify
viruses associated with Weddell seals (Leptonychotes weddellii) inhabiting the Ross Sea, vaginal
and nasal swabs, and faecal samples were collected between November 2014 and February 2015.
In addition, a Weddell seal kidney and South Polar skua (Stercorarius maccormicki) faeces were
opportunistically sampled. Using high throughput sequencing, we identified and recovered 152
anellovirus genomes that share 63-70% genome-wide identities with other pinniped anelloviruses.
Genome-wide pairwise comparisons coupled with phylogenetic analysis revealed two novel
anellovirus species, tentatively named torque teno Leptonychotes weddellii virus (TTLwV) -1 and
-2. TTLwV-1 (n=133, genomes encompassing 40 genotypes) is highly recombinant, whereas
TTLwV-2 (n=19, genomes encompassing three genotypes) is relatively less recombinant. This
study documents ubiquitous TTLwVs among Weddell seals in Antarctica with frequent coinfection by multiple genotypes, however, the role these anelloviruses play in seal health remains
unknown.

Introduction
Infectious diseases are the leading causes of mass mortality in wildlife and the global uptick of
emerging viral disease makes pathogen surveillance crucial for the protection of animal health
(Blomström, 2011; Dobson and Foufopoulos, 2001; Morner et al., 2002). However, identifying
viruses is difficult because traditional molecular techniques such as polymerase chain reaction
(PCR) amplification and serology-based assays are only useful for the detection of known viruses
and their close relatives (Symonds et al., 2009; Wang et al., 2002). Metagenomic approaches that
enrich for viruses and use high throughput sequencing platforms are powerful approaches for
revealing viral communities, including novel viruses, in animal populations (Delwart, 2007;
Edwards and Rohwer, 2005; Rosario and Breitbart, 2011).
Parts of Antarctica, a continent characterized by extreme climate and isolation, are inhabited by
unique wildlife. The dense breeding grounds of some animals creates an increased risk of
infectious diseases spreading amongst the population at an epidemic scale (Kerry et al., 1999).
Similarly, increased human activity on the continent through tourism and research bases is thought
to have exposed wildlife to diseases previously attributed to domestic animals. Such findings have
led to concerns about pathogen introduction associated with anthropogenic activities (Austin and
Webster, 1993; Gardner et al., 1997; Olsen et al., 1996; Retamal et al., 2000; Torres, 2000).
Unfortunately, little is known about the pathogens associated with Antarctic animals.
Within the context of viral pathogens identified in Antarctic wildlife, the use of sequencing
approaches has led to the identification of some viruses in Antarctic penguins, i.e. Adélie penguin
(Pygoscelis adeliae), Chinstrap penguins (Pygoscelis antarctica) and Gentoo penguins (Pygoscelis
papua), including an adenovirus, paramyxoviruses, orthomyxoviruses, a polyomavirus and a
papillomavirus (Hurt et al., 2016; Hurt et al., 2014; Lee et al., 2014; Lee et al., 2016; Thomazelli
et al., 2010; Varsani et al., 2014; Varsani et al., 2015). Similarly, a polyomavirus has been
identified in sharp-spined notothen (Trematomus pennelii), an Antarctic fish (Buck et al., 2016), a
parapoxvirus (Tryland et al., 2005) and a polyomavirus (Varsani et al., 2017) in Weddell seals
(Leptonychotes weddellii), and an adenovirus has been identified in South Polar skua (Stercorarius
maccormicki) (Park et al., 2012). In addition, serology-based assays have enabled the detection of

a putative birnavirus and flavivirus (Gardner et al., 1997; Morgan and Westbury, 1981; Morgan et
al., 1985) in penguins (Adélie penguin, Blue penguin; Eudyptula minor and Emperor penguin;
Aptenodytes forsteri), and a putative herpesvirus in Antarctic seals, namely Weddell seals and
crabeater seals (Lobodon carcinophaga) (Harder et al., 1991; Stenvers et al., 1992).
A recent health assessment testing Weddell seals for antibodies to specific known bacterial and
viral pathogens indicated that this population remains relatively naïve, leaving them potentially
vulnerable to mass die-offs due to their close living proximity and lack of herd immunity (Yochem
et al., 2009). Due to this vulnerability, it is important to identify viruses associated with these
populations. Viral surveys will provide insight into the viral diversity that is currently associated
with these seals, and will provide the genetic information necessary to develop new molecular
assays to assess the prevalence of identified viruses and begin to elucidate their impact on animal
health.
As part of an ongoing study on Weddell seals in the Ross Sea, we opportunistically sampled faeces,
and took nasal and vaginal swabs to identify viruses associated with these animals. In these
samples, as well as in a kidney sample from a deceased Weddell seal and a faecal sample from a
South Polar skua (a bird that scavenges placenta and carcasses of seals), we identified a diversity
of anelloviruses. Anelloviruses are non-enveloped, circular, negative sense, single-stranded DNA
viruses that belong to the family Anelloviridae (Biagini, 2009; Okamoto et al., 1998b). The first
anellovirus, human torque teno virus (TTV), was discovered in a Japanese patient with post
transfusion hepatitis of unknown etiology (Nishizawa et al., 1997).

Since then, numerous

anelloviruses have been characterized and grouped into 12 different genera, which have been
found in a variety of hosts including pigs, wild boar, dogs, seals, sea lions, pine marteen, bats,
horses, cats, sea turtles and a range of primates (Abe et al., 2000; Al-Moslih et al., 2007;
Fahsbender et al., 2015; King, 2011; Martinez et al., 2006; Ng et al., 2009a; Ng et al., 2009b; Ng
et al., 2011; Nishiyama et al., 2014; Okamoto et al., 2001; Romeo et al., 2000). Despite their
ubiquity and ability to cause persistent infections, the etiology of anelloviruses remains unknown.
Most of what is known about anelloviruses is based on human TTV, which has a prevalence as
high as 100% in some human populations (Ninomiya et al., 2008). Individuals frequently harbor

multiple TTV genotypes (Niel et al., 2000; Nishiyama et al., 2014) and these have been identified
throughout the body including in cervical secretions, nasal secretions, the umbilical cord, kidneys,
blood, gastric tissue, and sweat (Spandole et al., 2015). There is no indication of tropism, but
patterns of genotype compartmentalization, similar to human immunodeficiency virus, have been
documented within the host (Maggi et al., 1999).
Anelloviruses have been found to be highly diverse, even at the amino acid level of the coding
open reading frames (ORFs), yet the genome organization remains relatively similar with at least
two ORFs and a conserved untranslated region (UTR). ORF1 is the largest ORF and is predicted
to encode the capsid protein, however, this has not been definitively confirmed (Kamahora et al.,
2000; Okamoto et al., 2000). ORF2 encodes proteins thought to be involved in regulation of the
innate and adaptive immune system, but the lack of an appropriate culture system has hindered the
ability to determine the functionality of these proteins and TTV pathogenicity (Huang et al., 2012;
Kakkola et al., 2009; Kakkola et al., 2007; Yu et al., 2007).
Here we analyze the genomes of the anelloviruses recovered from faeces, kidney, and vaginal and
nasal swabs of Weddell seals and a faecal sample of a South Polar skua. Sequence analysis
revealed two phylogenetically distinct anellovirus species that are prevalent in all sample types,
indicating that anelloviruses are ubiquitous among Weddell seals.

Methods
Sample collection
As part of an ongoing diet study in the Ross Sea on Weddell seals, 42 Weddell seal faecal samples
were opportunistically collected on the fast ice of McMurdo Sound (Antarctic) during the
2014/2015 field season. Even though there were tagged animals in the vicinity of the faeces, it was
not possible to associate the sampled faeces to a particular tagged animal. In addition to these
samples, we collected paired nasal and vaginal swabs from Nov 2014 to Feb 2015 25 adult female
Weddell seals; for two additional animals, only nasal swabs were taken, and for three animals we
also collected faecal samples (Supplementary Table 1). A subset of females sampled in Nov / Dec
were resampled approximately 60 days later in Jan/Feb, providing an additional eight nasal and
nine vaginal samples. The nasal and vaginal swabs were refrigerated and stored in UTM™ Viral

Transport Media (Copan, USA). During the field season, a kidney was sampled from the carcass
of a 14-year-old female (Flipper Tag# 8714A; specimen ID 17461) and frozen at -80°C prior to
analysis, see Varsani et al. (2017) for necropsy details. Finally, a South Polar skua faecal sample
was collected off fresh snow at Cape Crozier, Ross Island.
All applicable international, national, and/or institutional guidelines for the care and use of animals
were followed. Weddell seal samples were collected under National Marine Fisheries Service
Marine Mammal permit #17411, Antarctic Conservation Act permit #2014-003, and University of
Alaska Anchorage’s Institutional Animal Care and Use Committee approval #419971, with
funding from the National Science Foundation grant ANT-1246463 to Jennifer M Burns. The skua
faecal sample at Cape Crozier was collected under Animal Care and Use Permit #4130 through
Oregon State University, Corvallis, OR, USA, and Antarctic Conservation Act Permit #2006-010
from NSF through H.T. Harvey & Associates.

Sample processing
For each sample, ~5 g of the faecal sample or tissue samples (in the case of the kidney) was
resuspended in 20 ml of SM buffer (0.1 M NaCl, 50 mM Tris/HCl – pH 7.4, 10 mM MgSO4) and
homogenized by vortexing for 30 sec. The suspension was centrifuged at 10000 × g for 10 mins.
Following this, the supernatant was sequentially filtered through 0.45 μm and 0.2 μm (pore size)
syringe filters. Three grams of PEG 8000 (Sigma, USA) was added to each of the filtrates and the
solution was mixed gently to resuspend the PEG. The resulting suspension was incubated
overnight at 4°C to precipitate virions. The solution was centrifuged at 10000 x g for 20 mins and
the resulting pellet was resuspended in 2 ml of SM buffer.
Viral DNA was extracted using the High Pure Viral Nucleic Acid Kit (Roche Diagnostics, USA)
from the resuspended virions (200 μl) from the faecal and kidney samples, and 200 μl of the
UTM™ Viral Transport Media in which the swabs were stored. We used rolling-circle
amplification (RCA) using the TempliPhi™ kit (GE Healthcare, USA) to randomly amplify
nucleic acids.

High throughput sequencing and sequence analysis

A 5 μl aliquot of the randomly-amplified DNA from each of the Weddell seals faecal samples,
nasal swabs and vaginal swabs was taken, pooled and labeled as WSP, WSN and WSV,
respectively. The enriched DNA from the Weddell seal kidney sample was labelled as WSK and
the faecal sample from the South Polar skua as SKP. The DNA samples WSP, WSN, WSV, WSK
and SKP were then processed to generate ~100 bp paired-end libraries for multiplex Illumina
sequencing and sequenced on an Illumina 2500 (Illumina, USA) platform at Macrogen Inc.
(Korea). The resulting paired-end reads were de novo assembled using ABySS v1.9 (Simpson et
al., 2009) with a k-mer of 64. Contigs of >750 nts were analyzed for viral-like sequences using
BLASTx (Altschul et al., 1990) against a local viral sequence database.
In all of the WSP, WSN, WSV, WSK and SKP de novo assembled contigs, we identified sequences
with similarities to anelloviruses. Based on these sequences we designed four pairs of abutting
primers (Supplementary Table 2) to screen and recover the complete anellovirus genomes from
each individual sample. The RCA product from each sample was used as a template for PCR
amplification using Kapa HiFi Hotstart DNA polymerase with the following thermal cycling
conditions: (95°C for 3 mins; 25 cycles of 98°C for 20 sec, 60°C for 15 sec, 72°C for 2 mins and
a final extension of 72°C for 3 min). The amplicons were resolved on a 0.7% agarose gel stained
with SYBR Safe (ThermoFisher, USA) and ~2 kb size fragments were excised, gel purified and
cloned into pJET1.2 plasmid vector (ThermoFisher, USA). The resulting recombinant plasmids
(five from each positive sample type) were Sanger sequenced by primer walking at Macrogen Inc.
(South Korea).
To investigate the anellovirus diversity detected in seals, the pairwise identities of the anellovirus
genomes and ORF1 sequences were determined using SDT v1.2 (Muhire et al., 2014). All
anellovirus sequences with a detectable complete ORF1 were downloaded from GenBank (on the
18th of March 2017). 727 ORF1 sequences (including 152 from this study) were translated, aligned
using MUSCLE (Edgar, 2004) and then back translated. The resulting alignment was used to infer
a Maximum likelihood phylogenetic tree using IQ-TREE (Nguyen et al., 2015) with GTR+I+G4
substitution model selected using ModelFinder (Kalyaanamoorthy et al., 2017). Branches with less
than 60% bootstrap support (1000 bootstrap iterations) were collapsed using TreeGraph2 (Stover
and Muller, 2010).

Evidence of recombination in the anelloviruses identified in this study was determined using RDP
4.58 (Martin et al., 2015) with default settings. Sequences were auto-masked for optimal
recombination detection and only events detected with more than three different methods
implemented in RDP 4.58 coupled with phylogenetic support for recombination and a p-value of
<0.05 were considered credible.

Results
Anellovirus identification and genome characterization
Analysis of the contigs from the de novo assembled reads from Illumina sequencing of WSP,
WSN, WSV, WSK and SKP samples revealed high abundance of anellovirus-like sequences,
polymavirus-like sequences from WSK which is reported in Varsani et al. (2017), circular
replication-associated protein encoding viral-like sequences and various DNA bacteriophages.
Given the high abundance of anellovirus-like sequences, we decided to focus on these for this
report. Since anelloviruses have small circular genomes, PCRs using abutting primers were
performed to recover 152 anellovirus genomes from the various samples, ranging in size from
2105 to 2212 nts. Analysis of the genome-wide pairwise identity of these revealed that the seal
associated anellovirus genomes share more than 64% pairwise identity (Figure 1). Of the 152
genomes identified, 74 genomes sharing more than 64% identity were recovered from seal faeces,
37 genomes sharing more than 70% identity from nasal swabs, 34 genomes sharing more than 72%
identity from vaginal swabs, and four genomes sharing more than 73% identity from the kidney.
In addition, three anellovirus genomes sharing more than 75% identity were recovered from South
Polar skua faeces. These Antarctic anelloviruses share ~63-70% genome-wide identities
(Supplementary Data 1) with other pinniped anelloviruses from Pacific harbor seals (Phoca
vitulina) sampled in USA (Pacific coast) and the Netherlands (HQ287751, KF373758, KF373760,
KM262781, KM262785).
Based on species demarcation criteria of 35% divergence of the ORF1 amino acid sequences
endorsed by the International Committee for the Taxonomy of Viruses (ICTV) (King, 2011), the
anelloviruses identified in this study represent two species for which we propose the name torque
teno Leptonychotes weddellii virus (TTLwV) -1 and -2. This species demarcation is also supported

by the phylogenetic analysis of the ORF1 protein sequences of the TTLwVs (Figure 2). The
genome organization of representatives from the two phylogenetically distinct anellovirus species,
TTLwV-1 and TTLwV-2, are illustrated in Figure 1. Both genomes have the same organization,
with three open reading frames and a hypothetical protein, and are approximately the same genome
size, ~2.1 kb. However, there are differences in ORF size and position, specifically for ORF3.
A Maximum likelihood phylogenetic analysis of all available complete ORF1 nucleotide
sequences from GenBank (n=727) show that TTLwVs are related to other anelloviruses discovered
in pinnipeds (Figure 2), and most closely related to the Pacific harbor seal anelloviruses and torque
teno Zalophus virus (Figures 2 and 3). In general, the ORF1 phylogenetic analysis (Supplementary
Figure 1) shows some level of host specificity and within lineages there appears to be a significant
level of concordance between the phylogenies of the anelloviruses and their hosts (host phylogeny
inferred with TimeTree; http://www.timetree.org/; (Hedges et al., 2015; Kumar et al., 2017)).
Furthermore, it is clear that there are two lineages of porcine-associated, pinniped-associated and
rodent-associated anelloviruses. Thus, it is highly likely that there were multiple diverse
anelloviruses that were circulating amongst the most recent common ancestor (MRCA) of
mammals. Within the hominoid-associated anelloviruses, those from chimpanzees (n=10) and
gorillas (n=3) appear to be interspersed with those from humans (Figure 2 and Supplementary
figure 1). Within the primate lineage, given the depth of sampling of non-human primates, it is
difficult to test for a coevolution hypothesis or infer any cross-species transmission events. The
mosquito-associated anelloviruses are almost certainly derived from a vertebrate blood meal (see
taxa marked with * in Supplementary Figure 2).
TTLwV-1 (n=133) was identified in the South Polar skua faeces, as well as the kidney, nasal and
vaginal swabs, and faeces from Weddell seals, while TTLwV-2 (n=19) was exclusively found in
seal faeces (Figure 3). All of the genomes identified belong to the pinniped clade, indicating that
the seal itself is the most probable host of all of TTLwVs.
Based on the distribution of the pairwise identities of TTLwV-1 and TTLwV-2 ORF1 nucleotide
sequences (Figure 4), we established that genomes with greater or equal to 87% identity should be

grouped into the same genotype. Accordingly, TTLwV-1 sequences were subdivided into a total
of 40 genotypes, while TTLwV-2 was subdivided into three genotypes (Figure 4).

Evidence of recombination
Evidence of recombination within the genomes was detected by analyzing each species
individually with RDP 4.58 (Martin et al., 2015). TTLwV-1 and TTLwV-2 genomes have differing
recombination patterns. 89% of TTLwV-1 sequences had at least one recombination event, while
only 26% of TTLwV-2 sequences had a recombination event (Figure 5). The majority of the
recombination events in TTLwV-1 were located in the highly conserved translated region (UTR),
which is similar to the recombination hotspots found in human TTV and in a global anellovirus
analysis (Lefeuvre et al., 2009; Worobey, 2000). In contrast with the cold spots in ORF1 of the
TTLwV-1 genome, TTLwV-2 has recombination hotspots in the coding regions, ORF1 and ORF3.
Recombination may be a driving force of anellovirus diversity, especially in TTLwV-1 (Figure 5).

Prevalence of TTLwV in Weddell seals
Paired nasal and vaginal swabs were collected from 25 seals and 76% (19/25) of these tested
positive for TTLwV-1 in at least one of the paired samples. When parsed individually, 64% of the
nasal swabs and 72% of the vaginal swabs were TTLwV-1 positive. None of these samples tested
positive for TTLwV-2. Of the 45 faecal samples collected, all were TTLwV positive, with 98%
positive for TTLwV-1 and 40% for TTLwV-2.
The number of genotypes per type of sample, and the prevalence of each genotype, illustrated in
Figure 4 and Supplementary Figure 2, show the most common genotypes of TTLwV-1 are 1, 8,
and 11, while genotype 2 completely dominates TTLwV-2. Notably TTLwV-1 genotype 1 was
also recovered from the South Polar skua faeces. The seal faeces, vaginal, and nasal swabs had
comparable diversity with 25, 24, and 21 characterized genotypes, respectively. Although a single
kidney sample was analyzed, four genotypes were identified in this organ. Additionally, while
most seals harbored one or two TTLwV-1 genotypes, a few seals harbored many more (maximum
n = 9 genotypes seal ID 16603; supplementary Figure 2).

There is no clear distribution pattern of the 40 genotypes of TTLwV-1, yet TTLwV-2 was only
found in the seal faeces (40% of the faecal samples). Since TTLwV-2 is related to other
anelloviruses isolated from pinnipeds, it is likely to also be infecting seals, but may have a different
and more specific tropism than TTLwV-1, which seems to have pan-tropism. The overlapping
genotypes of TTLwV-1 found in the faeces, nasal, and vaginal swabs suggest possible fecal-oral
transmission of this virus, and indicates that future studies may be able to test the faeces alone to
capture anellovirus diversity in seals.

TTLwV-1 identification in South Polar skua faeces
TTLwV-1 was recovered from South Polar skua faeces that was opportunistically sampled. South
Polar Skua faeces contained three TTLwV-1 genotypes (1, 13, 17; Figures 3 and 4), which were
also identified in the seal kidney, faeces, nasal, and vaginal swabs. The presence of various
TTLwV-1 genotypes in South Polar skua faeces may reflect viruses that are dietary in origin since
these predatory birds feed on Weddell seal placenta and scavenge seal carcasses, which may
contain TTLwV, hence the likely explanation for presence of this in its faeces.

Conclusion
The advent of NGS technology has proven to be a powerful tool for virus discovery and has
changed the field of virology. Here we took advantage of this technology to investigate viral
presence and diversity in Antarctic wildlife, which remains largely unknown. Previous studies of
Weddell seals have focused on wildlife exposure to known viruses, limiting our understanding of
the myriad of viruses present in this unique environment.
Samples tested from Weddell seals from the Ross Sea led to the discovery of 152 anellovirus
genomes. Sequencing complete genomes enabled the recognition of two new species, TTLwV-1
and TTLwV-2 and the role recombination plays in driving TTLwV diversity.

TTLwV is

phylogenetically related to the other pinniped-associated anelloviruses that were recovered from
the brain and lungs of the Pacific harbor seal, the lungs, liver, lymph nodes and tonsils of a
California sea lion (Zalophus californianus), and the faeces from subantarctic fur seals
(Arctocephalus tropicalis) and South American fur seals (Arctocephalus australis) (Bodewes et
al., 2013; Kluge et al., 2016; Ng et al., 2009b; Ng et al., 2011). However, this is the first time

anelloviruses have been characterized in Weddell seals and the first time they have been described
in Antarctic vertebrates.
Although anelloviruses cause persistent infections and are ubiquitous among humans and various
animal species, their etiology remains a mystery (Spandole et al., 2015). This was the first time a
prevalence study showed anelloviruses to be ubiquitous within a pinniped population, with
TTLwVs present in 100% of the seal fecal samples. TTLwV-1 genomes from the seal faeces were
related to those recovered from the vaginal and nasal swabs and kidney, indicating that these were
shedding from the seal itself and not infecting seal food sources. The fact that the same TTLwV1 genotypes were found within the seal tissues and faeces may also suggest that this anellovirus
species is transmitted through the faecal-oral route, which is a hypothesis proposed for the
transmission of TTV in humans (Okamoto et al., 1998a; Ukita et al., 1999). Although TTLwV-2
was only detected in faecal samples, phylogenetic analysis indicates that this species may also
infect seals. Failure to detect TTLwV-2 in the seal tissues tested here suggests that this species has
more specific tropism than TTLwV-1.
Nevertheless, sampling of Weddell seal faeces alone could give a broad perspective of anellovirus
diversity circulating within this Antarctic pinniped population. Sampling faeces may therefore be
a valuable, non-invasive sampling tool for capturing the diversity and prevalence of pinniped
anelloviruses. Previous prevalence studies of pinniped-associated anelloviruses screened the
serum and lungs, which may have greatly underestimated the prevalence of anelloviruses in
pinniped populations (Fahsbender et al., 2015; Ng et al., 2011).
Future studies focusing on the anelloviruses in Antarctica will provide insight into their presence
in other species and how they are transmitted through the food web. The South Polar skua faeces
derived TTLwVs are most likely acquired from scavenging Weddell seal placenta or carcasses.
Therefore, detection of TTLwV in South Polar skua faeces and Weddell seal samples may provide
an example of a situation in which viruses could be used as proxies for trophic interactions
(Dayaram et al., 2016; Godinho et al., 2017). Additionally, it remains to be determined whether
TTLwV is present in Antarctic surface waters, as has been shown for some anelloviruses in Italy
and Japan (Haramoto et al., 2005; Verani et al., 2006).

More work needs to be done to determine the role of TTLwVs in Weddell seal health. TTLwVs
are diverse and pervasive in this population, with individuals infected with multiple genotypes.
The health effects of infection by specific genotypes or co-infection with different genotypes
remain unknown. With the exception of the dead Weddell seal from which the kidney sample
infected with a polyomavirus (Varsani et al., 2017) was obtained, all other animals were in
apparent good health, with most sighted months and years following handling. Determining the
viral load of TTLwV may prove to be important for providing clues as to the strength of seal
immune systems since anellovirus loads are thought to be good indicators of immunosuppression
(Hofer, 2014).
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Figure legends and table text

Figure 1: (A) Distribution of genome-wide pairwise identities of TTLwVs from this study. (B)
Schematic genome organizations of representatives from TTLwV-1 and TTLwV-2 which
highlights three open reading frames and a hypothetical protein.
Figure 2: Maximum-likelihood phylogenetic tree inferred from aligned ORF1 sequences of all
publicly available anellovirus sequences together with those from this study. Branches with less
than 60% bootstrap support have been collapsed.
Figure 3: Maximum-likelihood phylogenetic tree inferred from aligned ORF1 sequences of
TTLwVs and other closely related anelloviruses. Branches with less than 60% bootstrap support
have been collapsed. TTLwV sequences from South Polar skua faeces (SKP) are shown with
dotted branches.
Figure 4: (A) Distribution of the genome-wide pairwise identities of TTLwV-1 and TTLwV-2
supporting 87% genotype demarcation for TTLwV-1 genome sequences. (B) Summary of
genotypes found in different sample types. Each bar represents one genome. Total number of
genotypes of TTLvW-1 and TTLvW-2 from each sample type are provided at the bottom.
Figure 5: Summary of recombinant regions identified in (A) TTLwV-1 (light green bars) and (B)
TTLwV-2 (dark green bars). Recombination breakpoint distribution plots for (C) TTLwV-1 and
(D) TTLwV-2, with breakpoint hot-spots indicated in red and cold-spots in blue. The dark and
light grey areas of the plots indicate 95 and 99% confidence intervals, respectively. Detectable
breakpoint positions are indicated by vertical lines at the top of the graphs. The thick black line
represents the plot of the number of breakpoints detected within the 200 nt window region (window
was moved along each of the represented alignments 1 nt at a time).

Supplementary Table 1: Summary of samples used in this study.
Supplementary Table 2: Details of abutting primers used to recover the full genomes of TTLwV.

Supplementary Table 3: Summary of the recombination events detected in TTLwV-1 and -2.
Supplementary Figure 1: Maximum-likelihood phylogenetic tree inferred from aligned ORF1
sequences

of
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phylogeny

inferred

with
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(http://www.timetree.org/) (Hedges et al., 2015; Kumar et al., 2017). * marks sequences derived
from mosquitoes and thus likely of vertebrate origin sampled during a blood meal by the insects.
Supplementary Figure 2: Summary of TTLwV genotypes recovered from various sample types
and individual samples. Unless stated, each colour coded square represents one genome.
Supplementary Data 1: Genome-wide pairwise identities of Antarctic anelloviruses and other
closely related pinniped anelloviruses from Phoca vitulina sampled in USA and the Netherlands
(HQ287751, KF373758, KF373760, KM262781, KM262785).
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Homo sapiens

Primate

Pan troglodytes

Primate

Saguinus midas

Primate

Macaca fuscata

Rodentia

Microtus agrestis

Rodentia

Myodes glareolus

Rodentia

Rattus norvegicus

Rodentia

Apodemus sylvaticus
0.3 nucleotide substituions per site

Species
Leptonychotes weddellii
Phoca vitulina
Zalophus californianus

0.3 nucleotide substituions per site

TTLwV-1

60
62
64
66
68
70
72
74
76
78
80
82
84
86
88
90
92
94
96
98
100

Torque teno zalophus virus 1 2140
Seal anellovirus 2 2149
Seal anellovirus 6 2143
Seal anellovirus 3 2169
Seal anellovirus 7 2165
Seal anellovirus TFFN 2164
gt3 wsp24
gt3 wsp39
gt wsp24
gt2 wsp7
gt2 wsp11
gt2 wsp20
gt2 wsp28
gt2 wsp19
gt2 wsp31
gt2 wsp12
gt2 wsp25
gt2 wsp26
gt2 wsp37
gt2 wsp32
gt2 wsp45
gt2 wsp42
gt2 wsp33
gt2 wsp18
gt2 wsp8
gt39 wsp11
gt36 wsn34
gt38 wsp19
gt37 wsp9
gt37 wsp10
gt40 wsp2
gt40 wsp43
gt16 wsv41
gt16 wsn8
gt16 wsp8
gt15 wsp1
gt14 wsk
gt14 wsv34
gt14 wsv41
gt29 wsn25
gt30 wsn39
gt31 wsn35
gt32 wsv45
gt33 wsn34
gt33 wsp47
gt33 wsn38
gt33 wsv38
gt35 wsp46
gt35 wsv23
gt34 wsn39 5
gt34 wsn34
gt34 wsn39 2
gt24 wsv35
gt23 wsp21
gt23 skp1
gt23 wsn7
gt24 wsv34
gt24 wsn22
gt24 wsn38
gt25 wsn39
gt26 wsp39
gt27 wsn38
gt28 wsv44
gt18 wsv13
gt18 wsn33
gt18 wsv15
gt17 wsp41
gt17 wsv22
gt17 wsp7
gt17 wsp38
gt17 wsp29
gt17 wsv38
gt17 wsv35 3
gt17 wsv35 1
gt17 skp1
gt17 wsv35 2
gt22 wsn22
gt22 wsk
gt22 wsn4
gt21 wsp27
gt21 wsv38
gt19 wsv40
gt19 wsv25
gt19 wsn21
gt19 wsv36
gt20 wsn24
gt20 wsn24 2
gt20 wsv22
gt20 wsp36
gt20 wsv39
gt13 wsp22
gt13 wsp17
gt13 wsp12
gt13 wsp48
gt12 wsn38
gt12 wsp31
gt12 wsp26
gt12 wsv28
gt11 wsp37
gt11 wsv11
gt11 wsn25
gt11 wsp47
gt11 wsp32
gt11 wsv25
gt11 wsn34
gt11 wsp7
gt11 wsp31
gt11 wsp24
gt11 wsp33
gt11 wsp12
gt11 wsp10
gt11 wsp8
gt11 wsp4
gt11 wsp16
gt11 wsp23
gt11 wsp25
gt10 wsv34
gt9 wsv26
gt9 wsv8
gt9 wsp16
gt9 wsn32
gt9 wsn44
gt6 wsn30
gt7 wsn41
gt8 wsp14
gt8 wsp15
gt8 wsv8
gt8 wsp3
gt8 wsp13
gt8 wsp40
gt8 wsv37
gt8 wsp4
gt8 wsv41
gt8 wsn4
gt8 wsn8
gt5 wsp42
gt5 wsn34
gt5 wsv22
gt5 wsp23
gt5 wsp25
gt4 wsp35
gt3 wsn4
gt2 wsv10
gt2 wsv8
gt2 wsn4
gt2 wsv25
gt2 wsv34
gt2 wsk
gt2 wsp20
gt1 wsp44
gt1 wsp33
gt1 wsp34
gt1 skp1
gt1 wsp18
gt1 wsk
gt1 wsp28
gt1 wsn8
gt1 wsv7

TTLwV-2

Branch support

FJ459582
KF373760
KM262785
KF373758
KM262781
HQ287751
KY246547
KY246573
KY246548
KY246590
KY246587
KY246541
KY246556
KY246539
KY246560
KY246529
KY246551
KY246553
KY246570
KY246562
KY246581
KY246578
KY246565
KY246537
KY246584
KY246585
KY246496
KY246538
KY246523
KY246524
KY246518
KY246579
KY246622
KY246516
KY246582
KY246517
KY246480
KY246607
KY246621
KY246488
KY246504
KY246498
KY246624
KY246494
KY246526
KY246501
KY246616
KY246522
KY246599
KY246505
KY246495
KY246502
KY246611
KY246542
KY246478
KY246513
KY246606
KY246484
KY246500
KY246503
KY246572
KY246506
KY246623
KY246594
KY246492
KY246595
KY246576
KY246596
KY246521
KY246571
KY246557
KY246615
KY246612
KY246609
KY246476
KY246610
KY246485
KY246481
KY246508
KY246554
KY246617
KY246619
KY246600
KY246483
KY246613
KY246487
KY246486
KY246598
KY246568
KY246618
KY246543
KY246535
KY246527
KY246531
KY246499
KY246558
KY246552
KY246604
KY246569
KY246593
KY246489
KY246586
KY246561
KY246602
KY246493
KY246589
KY246559
KY246546
KY246564
KY246528
KY246525
KY246583
KY246574
KY246534
KY246545
KY246550
KY246605
KY246603
KY246626
KY246533
KY246491
KY246512
KY246490
KY246511
KY246588
KY246532
KY246591
KY246519
KY246530
KY246575
KY246614
KY246520
KY246620
KY246507
KY246514
KY246577
KY246497
KY246597
KY246544
KY246549
KY246567
KY246510
KY246592
KY246627
KY246509
KY246601
KY246608
KY246479
KY246540
KY246580
KY246563
KY246566
KY246477
KY246536
KY246482
KY246555
KY246515
KY246625

Sample type
SKP
WSK
WSP
WSV
WSN

Genotypes SKP WSK WSP

B

0.20

0.15

TTLwV-2

Proportion of pairwise identities

0.10

TTLwV-1

TTLwV-2

0.05

0.00

0.05

0.10

0.15

0.20

0.25

TTLwV-1

0.00

67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 Percentage pairwise identities

A

1

WSN Genomes
10

2

7

3

1

4

1

5

5

6

1

7

1

8

10

9

5

10

1

11

18

12

4

13

5

14

3

15

1

16

3

17

9

18

4

19

4

20

4

21

2

22

3

23

2

24

5

25

1

26

1

27

1

28

1

29

1

30

1

31

1

32

1

33

4

34

2

35

2

36

1

37

2

38

1

39

1

40

2

1

1

2

17

3

2
3

4

25

WSV

24

21

orf2

orf3

orf1

orf3

TTLwV-2 gt wsp24
TTLwV-2 gt2 wsp11
TTLwV-2 gt2 wsp12
TTLwV-2 gt2 wsp18
TTLwV-2 gt2 wsp19
TTLwV-2 gt2 wsp20
TTLwV-2 gt2 wsp25
TTLwV-2 gt2 wsp26
TTLwV-2 gt2 wsp28
TTLwV-2 gt2 wsp31
TTLwV-2 gt2 wsp32
TTLwV-2 gt2 wsp33
TTLwV-2 gt2 wsp37
TTLwV-2 gt2 wsp42
TTLwV-2 gt2 wsp45
TTLwV-2 gt2 wsp7
TTLwV-2 gt2 wsp8
TTLwV-2 gt3 wsp24
TTLwV-2 gt3 wsp39

C

hypothetical

TTLwV-1

orf2

orf1

orf3

22.0

16.5

11.0

5.5

2122

1592

530

1061

0.0
1

Nucleotide position in relation to TTLwV-1 gt1 skp1

hypothetical

TTLwV-2

orf2

orf1

orf3

3.00

2.25

1.50

0.75

2135

0.00
1602

D

534

orf1

hypothetical

TTLwV-2

1

orf2
TTLwV-1 gt1 skp1
TTLwV-1 gt1 wsk
TTLwV-1 gt1 wsn8
TTLwV-1 gt1 wsp18
TTLwV-1 gt1 wsp28
TTLwV-1 gt1 wsp33
TTLwV-1 gt1 wsp34
TTLwV-1 gt1 wsp44
TTLwV-1 gt1 wsv7
TTLwV-1 gt10 wsv34
TTLwV-1 gt11 wsn25
TTLwV-1 gt11 wsn34
TTLwV-1 gt11 wsp10
TTLwV-1 gt11 wsp12
TTLwV-1 gt11 wsp16
TTLwV-1 gt11 wsp23
TTLwV-1 gt11 wsp24
TTLwV-1 gt11 wsp25
TTLwV-1 gt11 wsp31
TTLwV-1 gt11 wsp32
TTLwV-1 gt11 wsp33
TTLwV-1 gt11 wsp37
TTLwV-1 gt11 wsp4
TTLwV-1 gt11 wsp47
TTLwV-1 gt11 wsp7
TTLwV-1 gt11 wsp8
TTLwV-1 gt11 wsv11
TTLwV-1 gt11 wsv25
TTLwV-1 gt12 wsn38
TTLwV-1 gt12 wsp26
TTLwV-1 gt12 wsp31
TTLwV-1 gt12 wsv28
TTLwV-1 gt13 wsp12
TTLwV-1 gt13 wsp17
TTLwV-1 gt13 wsp22
TTLwV-1 gt13 wsp48
TTLwV-1 gt14 ws
TTLwV-1 gt14 wsv34
TTLwV-1 gt14 wsv41
TTLwV-1 gt15 wsp1
TTLwV-1 gt16 wsn8
TTLwV-1 gt16 wsp8
TTLwV-1 gt16 wsv41
TTLwV-1 gt17 skp1
TTLwV-1 gt17 wsp29
TTLwV-1 gt17 wsp38
TTLwV-1 gt17 wsp41
TTLwV-1 gt17 wsp7
TTLwV-1 gt17 wsv22
TTLwV-1 gt17 wsv35 1
TTLwV-1 gt17 wsv35 2
TTLwV-1 gt17 wsv35 3
TTLwV-1 gt17 wsv38
TTLwV-1 gt18 wsn33
TTLwV-1 gt18 wsv13
TTLwV-1 gt18 wsv15
TTLwV-1 gt19 wsn21
TTLwV-1 gt19 wsv25
TTLwV-1 gt19 wsv36
TTLwV-1 gt19 wsv40
TTLwV-1 gt2 wsk
TTLwV-1 gt2 wsn4
TTLwV-1 gt2 wsp20
TTLwV-1 gt2 wsv10
TTLwV-1 gt2 wsv25
TTLwV-1 gt2 wsv34
TTLwV-1 gt2 wsv8
TTLwV-1 gt20 wsn24
TTLwV-1 gt20 wsn24 2
TTLwV-1 gt20 wsp36
TTLwV-1 gt20 wsv22
TTLwV-1 gt20 wsv39
TTLwV-1 gt21 wsp27
TTLwV-1 gt21 wsv38
TTLwV-1 gt22 ws22
TTLwV-1 gt22 wsk
TTLwV-1 gt22 wsn4
TTLwV-1 gt23 skp1
TTLwV-1 gt23 wsn7
TTLwV-1 gt23 wsp21
TTLwV-1 gt24 wsn22
TTLwV-1 gt24 wsn38
TTLwV-1 gt24 wsv34
TTLwV-1 gt24 wsv35
TTLwV-1 gt25 wsn39
TTLwV-1 gt26 wsp39
TTLwV-1 gt27 wsn38
TTLwV-1 gt28 wsv44
TTLwV-1 gt29 wsn25
TTLwV-1 gt3 wsn4
TTLwV-1 gt30 wsn39
TTLwV-1 gt31 wsn35
TTLwV-1 gt33 wsv34
TTLwV-1 gt33 wsv38
TTLwV-1 gt33 wsn38
TTLwV-1 gt33 wsp47
TTLwV-1 gt33 wsv38
TTLwV-1 gt34 wsn34
TTLwV-1 gt34 wsn39 2
TTLwV-1 gt34 wsn39 5
TTLwV-1 gt35 wsp46
TTLwV-1 gt35 wsv23
TTLwV-1 gt36 wsn34
TTLwV-1 gt37 wsp10
TTLwV-1 gt37 wsp9
TTLwV-1 gt38 wsp19
TTLwV-1 gt39 wsp11
TTLwV-1 gt4 wsp35
TTLwV-1 gt40 wsp2
TTLwV-1 gt40 wsp43
TTLwV-1 gt5 wsn34
TTLwV-1 gt5 wsp23
TTLwV-1 gt5 wsp25
TTLwV-1 gt5 wsp42
TTLwV-1 gt5 wsv22
TTLwV-1 gt6 wsn30
TTLwV-1 gt7 wsn41
TTLwV-1 gt8 wsn4
TTLwV-1 gt8 wsn8
TTLwV-1 gt8 wsp13
TTLwV-1 gt8 wsp14
TTLwV-1 gt8 wsp15
TTLwV-1 gt8 wsp3
TTLwV-1 gt8 wsp4
TTLwV-1 gt8 wsp40
TTLwV-1 gt8 wsv37
TTLwV-1 gt8 wsv41
TTLwV-1 gt8 wsv8
TTLwV-1 gt9 wsn32
TTLwV-1 gt9 wsn44
TTLwV-1 gt9 wsp16
TTLwV-1 gt9 wsv26
TTLwV-1 gt9 wsv8

B

1068

hypothetical

Breakpoints per 200 nt window

TTLwV-1

Breakpoints per 200 nt window

A

Nucleotide position in relation to TTLwV-2 gt wsp24
Breakpoint number
Local 95% confidence interval
Local 99% confidence interval
Global 95% confidence limit
Global 99% confidence limit

Recombination hotspot
Recombination coldspot

*
**

20 MYA

0.3 nucleotide substituions per site

Order
Artiodactyla
Carnivora
Carnivora
Carnivora
Carnivora
Carnivora
Carnivora
Chiroptera
Equine
Primate
Primate
Primate
Primate
Primate
Primate
Primate
Rodentia
Rodentia
Rodentia
Rodentia

Species
Sus scrofa
Canis lupus
Leptonychotes weddellii
Phoca vitulina
Zalophus californianus
Martes martes
Felis catus
Tadarida brasiliensis
Equus caballus
Aotus sp.
Chlorocebus sabaeus
Gorilla gorilla
Homo sapiens
Pan troglodytes
Saguinus midas
Macaca fuscata
Microtus agrestis
Myodes glareolus
Rattus norvegicus
Apodemus sylvaticus

Nasal
WSN04; WS14-04
WSN06; WS14-06
WSN07; WS14-07
WSN08; WS14-08
WSN09; WS14-09
WSN10; WS14-10
WSN11; WS14-11
WSN13; WS14-13
WSN15; WS14-15
WSN21; WS14-21
WSN22; WS14-22
WSN23; WS14-23
WSN24; WS14-24
WSN25; WS14-25
WSN28; WS14-28
WSN29; WS14-29
WSN30; WS14-30
WSN31; WS14-31
WSN32; WS14-32
WSN34; WS14-34
WSN35; WS14-35
WSN37; WS14-37
WSN38; WS14-38
WSN42; WS14-42
WSN43; WS14-43
WSN44; WS14-44
WSN46; WS14-46

Nasal (resampled)

WSN39; WS14-39
WSN41; WS14-41
WSN33; WS14-33
WSN27; WS14-27
WSN45; WS14-45
WSN36; WS14-36
WSN40; WS14-40
WSN26; WS14-26

Vaginal
WSV04; WS14-04
WSV06; WS14-06
WSV07; WS14-07
WSV08; WS14-08
WSV09; WS14-09
WSV10; WS14-10
WSV11; WS14-11
WSV13; WS14-13
WSV15; WS14-15
WSV21; WS14-21
WSV22; WS14-22
WSV23; WS14-23
WSV24; WS14-24
WSN14; WS14-14
WSV28; WS14-28
WSV29; WS14-29
WSV30; WS14-30
WSV31; WS14-31
WSV32; WS14-32
WSV34; WS14-34
WSV35; WS14-35
WSV37; WS14-37
WSV38; WS14-38
WSV43; WS14-43
WSV05; WS14-05

Vaginal (resampled)

Faeces

WSV39; WS14-39
WSV41; WS14-41

WSP46; WS14-08

WSV27; WS14-27

WSP47; WS14-11

Kidney

WSV45; WS14-45
WSV36; WS14-36
WSV40; WS14-40
WSV26; WS14-26
WSV25; WS14-25

WSP48; WS14-14

WSV44; WS14-44
WSP01; SK3
WSP02; SK15
WSP03; SK20
WSP04; SK21
WSP07; SK24
WSP08; SK25
WSP09; SK26
WSP10; SK27
WSP11; SK28
WSP12; SK29
WSP13; SK30
WSP14; SK32
WSP15; SK34
WSP16; SK35
WSP17; SK36
WSP18; SK37
WSP19; SK38
WSP20; SK39
WSP21; BR1
WSP22; BR2
WSP23; BR3
WSP24; BR4
WSP25; HC1
WSP26; HC2
WSP27; HC3
WSP28; HC4
WSP29; HC5
WSP30; HC6
WSP31; HC7
WSP32; HC8
WSP33; HC9
WSP34; HC10
WSP35; HC11
WSP36; HC12
WSP37; HC13
WSP38; TR1
WSP39; TR2
WSP40; TR3
WSP41; TR4
WSP42; TR5
WSP43; RB5
WSP44; RB6
WSP45; HC6
WSK

Primer
anello1_F
anello1_R
anello2_F
anello2_R
12092anello_F
12092anello_R
12124anello_F
12124anello_R
12421anello_F
12421anello_R

TTLwV type
1
1
1
1
2

Sequence (5'→3')
AGAAGAAAGAGAATCTCCGTTMGAGGTTGGG
CCGTGAGGGGTAATATCTTACTGTAGC
GAAAATCTGATTGGCTGCCCGGGATG
TTCCGCTTTTTAAAACCCACTTTTCGAGGTAC
AAAAACCTCCTCTATAGAGCTCAGTACTAC
GAAGGTAAAGAAATGGTGACCCCAGG
CCATAATTATCCATTGGGTCTGAGAAG
CAGATGGGGACCCTTCTGTCCATATG
TGGGAAGGACTCTTTAATCTACCATCAGC
GCTAGCAGGGGGTCTCACGTATACT

APPENDIX 2: DISCOVERY OF A NOVEL CIRCULAR DNA VIRUS IN THE FORBES SEA
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Abstract A single-stranded DNA (ssDNA) virus, Asterias forbesi-associated circular virus (AfaCV), was discovered in a Forbes sea star displaying symptoms of sea
star wasting disease (SSWD). The AfaCV genome organization is typical of circular Rep-encoding ssDNA
(CRESS-DNA) viruses and is similar to that of members of
the family Circoviridae. PCR-based surveys indicate that
AfaCV is not clearly associated with SSWD, whereas the
sea star-associated densovirus (SSaDV), recently implicated in SSWD in the Paciﬁc, was prevalent in symptomatic specimens. AfaCV represents the ﬁrst CRESSDNA virus detected in echinoderms, adding to the growing
diversity of these viruses recently recovered from
invertebrates.
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Sea stars (Asterozoa) are keystone predators in the marine
environment, essential for structuring intertidal invertebrate communities that are critical for ecosystem health
[15]. Sea star wasting disease (SSWD), which is characterized by white epidermal lesions, deﬂation, limb autotomy, and in most cases, eventual death (‘‘melting’’), is
currently affecting multiple species of asteroids in both the
Atlantic and Paciﬁc oceans. A study investigating SSWD
in asteroids from the Northeast Paciﬁc Ocean implicated a
densovirus (sea star-associated densovirus; SSaDV) as the
most likely cause of SSWD in the region [9]. To evaluate if
other viruses could be associated with this disease in the
Atlantic Ocean, viral metagenomics was performed on
Forbes sea star (Asterias forbesi) specimens from the
Northwest Atlantic coast that were exhibiting SSWD
symptoms.
Visually healthy Asterias forbesi collected from Point
Judith Pond, Rhode Island, in June of 2011 later developed
signs of SSWD in captivity, and two individuals were sent
to the University of South Florida for viral metagenomic
analysis. Upon receipt, samples were ﬂash frozen in liquid
nitrogen, and gut contents were removed before crushing
each sample inside a sterile Whirl-PakÒ. Asteroid tissue
was homogenized in sterile 1X phosphate-buffered saline
(PBS) solution using a bead-beater (BioSpec, USA) with
1.0-mm glass beads (Research Products International,
USA) for 1 min. Virus particles were puriﬁed from
homogenates by pelleting the cells by centrifugation at
6,000 9 g for 6 min and ﬁltering the supernatant through a
0.22-lm Sterivex ﬁlter (Millipore, USA). The ﬁltrate was
treated with 0.2 volumes of chloroform, followed by 2.5 U
of DNase I per ll at 37 °C for 3 hours to degrade nonencapsidated nucleic acids [13, 14]. EDTA was then added
at a ﬁnal concentration of 20 mM to inactive the nuclease
activity. Viral DNA was extracted from the puriﬁed viral
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particles using a QIAamp MinElute Virus Spin Kit (QIAGEN, USA) and then ampliﬁed and fragmented using a
GenomePlex Whole Genome Ampliﬁcation (WGA) Kit
(Sigma-Aldrich) according to the manufacturers’ protocols.
The resulting fragmented DNA was puriﬁed using a
UltraCleanÒ PCR Clean-Up Kit (MO BIO, USA) and
sequenced at a next-generation sequencing service provider
using an Illumina HiSeq 2000 (Illumina, USA) instrument.
The metagenomic single-end reads were de novo
assembled using Assembly By Short Sequences (ABySS)
[19], and viral contigs were identiﬁed through BLAST [1]
analysis. Back-to-back primers (Seastarcirco_Fout 5’-TCT
CAA TGG TGG GAT GGA TA-3’ and Seastarcirco_Rout
5’-TCT CTG CTT CCA GTA GGC GT-3’) were then
designed based on a contig exhibiting signiﬁcant similarities to circular single-stranded DNA (ssDNA) viruses and
utilized for inverse PCR to complete and verify the genome
sequence. Viral DNA was extracted using a QIAamp
MinElute Virus Spin Kit (QIAGEN, USA) and ampliﬁed
through rolling-circle ampliﬁcation (RCA), which is
known to enrich for small circular templates [10, 11], using
the illustra GenomiPhi V2 Kit (GE Healthcare, USA). This
ampliﬁed DNA was used as the template for the inverse
PCR assay using a Herculase II Fusion Polymerase Kit
(Agilent Technologies, USA) under the following conditions: 95 °C for 4 minutes, 45 cycles of 95 °C for
20 seconds, 53 °C for 20 seconds with a touchdown of
-0.1 °C per cycle, and 72 °C for 2 minutes, followed by a
ﬁnal extension at 72 °C for 5 minutes. The PCR product
was cloned using a TOPO TA Cloning Kit (Invitrogen,
USA) and commercially Sanger sequenced by primer
walking.
The metagenomics approach resulted in the discovery of
a novel circular ssDNA genome, named Asterias forbesiassociated circular virus (AfaCV). The AfaCV genome
(GenBank accession number KR186219) is 2414 nt in
length with two major open reading frames (ORFs)
encoding a replication initiator protein (Rep) and a putative
capsid protein (Cap) in an ambisense orientation (Fig. 1).
The genome also exhibits a putative origin of replication
marked by a conserved nonanucleotide motif (TAGTATTAC) at the apex of a hairpin structure. This genome
organization is typical of circular Rep-encoding ssDNA
(CRESS-DNA) viruses of the family Circoviridae, specifically members of the proposed genus Cyclovirus [12, 18].
The AfaCV Rep shares 52 % identity with that of a
CRESS-DNA virus discovered in an estuarine mollusk
(GenBank accession number AJP36419.1) [4], whereas the
putative Cap shares 40 % identity with a CRESS-DNA
virus discovered in dragonﬂy larvae (GenBank accession
number YP_009001744) [3]. Similar to members of the
Circoviridae, the AfaCV putative Cap contains an arginine-rich region within the ﬁrst 50 amino acids.
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Fig. 1 Schematic genome organization of AfaCV. The ﬁgure highlights a replication-initiator ORF (Rep; light gray), a putative capsid
ORF (Cap; dark gray), and a stem-loop structure containing the
conserved nonanucleotide motif (TAGTATTAC). The black star
represents the TATA box

To explore the association of the novel AfaCV with
SSWD, 48 SSWD-affected A. forbesi sea stars collected
from Westerly, Rhode Island, in February of 2013 were
tested for both AfaCV and the previously described SSaDV
by PCR. DNA was extracted from sea star arm tissue using
a ZR Tissue and Insect DNA MiniPrep Kit (Zymo, USA)
and enriched by RCA using an illustra TempliPhi Kit (GE
Healthcare, USA) for use as the template for both PCR
assays. Primers AfaCV_2283F (5’-CTG TCC TCC TTT
GGT TTC CA-3’) and AfaCV_65R (5’-CTG GAT TTT
CCT GTT CCT GTT G-3’) were designed to target a
197-nt region of AfaCV. The PCR (containing 1 lM each
primer, 200 lM dNTPs, 1 U of Red Taq [Sigma-Aldrich],
1X Red Taq reaction buffer and 1 ll of DNA template in a
50-ll reaction) proceeded as follows: 95 °C for 5 minutes,
45 cycles of 94 °C for 1 minute, 54 °C for 1 minute with a
touchdown of -0.1 °C per cycle, and 72 °C for 30 seconds,
followed by a ﬁnal extension at 72 °C for 10 minutes. PCR
products of the correct size were cloned using a TOPO TA
Cloning Kit (Invitrogen) and Sanger sequenced to conﬁrm
their identity as AfaCV and verify the speciﬁcity of the
assay through comparisons against GenBank. Only ﬁve of
the 48 samples tested (10 %) were positive for AfaCV,
showing that AfaCV is unlikely to be associated with

Novel circular DNA virus in Forbes sea star

SSWD in the Atlantic Ocean. Previously published primers
for the VP4 region of SSaDV [9] were used to screen these
same samples for SSaDV. The PCR (containing 1 lM each
primer, 200 lM dNTPs, 1 U of Red Taq [Sigma-Aldrich],
1X Red Taq reaction buffer and 1 ll of DNA template in a
50-ll reaction) proceeded as follows: 95 °C for 5 minutes,
45 cycles of 94 °C for 1 minute, 56 °C for 1 minute with a
touchdown of -0.1 °C per cycle, and 72 °C for 30 seconds,
followed by a ﬁnal extension at 72 °C for 10 minutes.
Twenty-three of the 48 samples (48 %) were positive for
SSaDV; however, this may be an underestimation of the
true SSaDV prevalence due the use of standard PCR, which
is less sensitive than quantitative PCR using an internal
TaqMan probe. Nevertheless, SSaDV appears to be associated with SSWD in Atlantic Forbes sea stars, similar to
the ﬁndings of Hewson et al. [9] in the Paciﬁc.
Recent metagenomic studies have revealed that CRESSDNA viruses similar to members of the Circoviridae are
more widespread than previously thought and may thrive in
a wide variety of hosts, including invertebrates [18].
Speciﬁcally, these viruses have been identiﬁed in insects
[2, 5, 16, 17], copepods [6], mollusks [4] and water ﬂeas
[8]. Although recent studies have identiﬁed linear ssDNA
densoviruses in echinoderms [7, 9], AfaCV is the ﬁrst
CRESS-DNA virus identiﬁed in echinoderms and provides
further support that these viruses may infect a wider host
range than previously thought. Therefore, although AfaCV
has no association with SSWD, future studies are needed to
determine the prevalence of AfaCV and other CRESSDNA viruses amongst various sea star species and elucidate their roles in the ecology of these keystone predators.
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Abstract
Fibropapillomatosis (FP) is a debilitating disease of panzootic proportions affecting all hard
shelled sea turtles, including green (Chelonia mydas), loggerhead (Caretta caretta), and Kemp's
ridley (Lepidochelys kempii). There is overwhelming evidence suggesting this neoplastic disease
is caused by the chelonid fibropapillomatosis-associated herpesvirus (CFPHV; Chelonid
herpesvirus 5, ChHV5). Unfortunately, all attempts to culture this virus, a precursor needed to
fulfill Koch's postulates, have failed. The lack of a culture system has hindered efforts to
understand the role of ChHV5 in FP, highlighting the need for molecular studies. Currently, the
only genome available of ChHV5 was sequenced from the glottis tumor of a Hawaiian green sea
turtle using the bacterial artificial clone (BAC) system. To sequence ChHV5 from tumors of
Florida green, loggerhead, and Kemp’s ridley sea turtles, this study used the Hawaiian genome
as a scaffold for long-range PCR followed by Illumina sequencing of amplicons; however, long
regions of repeat sections (> 9 kb) have impeded genome completion. Preliminary data was used
to create an updated ChHV5 phylogeny using a 4,152 bp region of the capsid gene. This new
phylogeny contradicts previous phylogenies constructed with other genes, indicating that the
topology is dependent on the gene analyzed. Currently, efforts are under way to recover full
genomes through target enrichment and PacBio sequencing, in order to enable genome-wide
phylogenetic comparisons and provide insight into ChHV5 evolution.

Introduction
Chelonid fibropapillomatosis-associated herpesvirus (CFPHV; Chelonid herpesvirus 5, ChHV5)
is most likely the etiological agent of fibropapillomatosis (FP) (Lackovich, et al. 1999; Lu, et al.
2000a; Lu, et al. 2000b; Quackenbush, et al. 1998), which is considered the most significant
neoplastic disease in reptiles due to its rapid increase in sea turtle populations and worldwide
prevalence (Herbst 1994). This debilitating disease has reached panzootic proportions and while
it primarily affects green sea turtles (Chelonia mydas), it has been documented in all hard shelled
sea turtles, including loggerheads (Caretta caretta) and Kemp’s ridley (Lepidochelys kempii)
(Alfaro-Núñez and Gilbert 2014). FP manifests as cutaneous fibropapillomas or fibromas and in
severe cases, internal fibromas, myxofibromas, or fibrosarcomas (Herbst 1994; Work, et al.
2004). These tumors can interfere with feeding, predator avoidance, buoyancy, hydrodynamics,
and vision, ultimately contributing to mortality and stranding events (Brooks, et al. 1994;
Jacobson, et al. 1989; Lucke 1938; Smith and Coates 1938). In especially severe cases, FP may
lead to immunosuppression, secondary bacterial infections, emaciation and death (Work and
Balazs 1999; Work, et al. 2003).

FP has been documented in Florida’s waters since the late 1930’s (Smith and Coates 1938), but
has been reported in increasing numbers over the past two decades (Foley, et al. 2005; Herbst
1994). In some regions of Florida (including the Indian River Lagoon, the Florida Keys, and the
Gulf coast), FP affects >50% of the green turtles (Coberley 2002; Foley, et al. 2005; Greenblatt,
et al. 2005a). Spontaneous tumor regression in sea turtles that are not severely afflicted with FP
has been documented since the 1990's, but the mechanism of regression is unknown (Aguirre, et
al. 1999; Bennett, et al. 1999; Ehrhart 1991). Although FP may not be lethal to all sea turtles,

this disease has severely affected Florida’s sea turtles and due to its prevalence in juvenile
animals, it poses a threat to these endangered animals.

Numerous attempts to isolate and culture ChHV5 have failed, leaving Koch's postulates
unfulfilled and limiting our ability to definitively conclude the role of this virus in the disease.
Nevertheless, there is strong evidence that ChHV5 plays an important role in the development of
FP. Transmission studies implicate an enveloped virus as the etiological agent of FP (Herbst, et
al. 1995; Herbst, et al. 1996) and transmission electron microscopy (TEM) of tumors revealed
herpesvirus-like particles, which correlate in size and chloroform sensitivity to the transmission
experiments (Herbst, et al. 1996). Additionally, herpesviral DNA sequences have been detected
by PCR in the tumors of FP symptomatic turtles from around the world. Quantitative PCR of the
DNA polymerase gene shows that ChHV5 concentrations are 2.5 to 4.5 logs higher and gene
expression is over 200-fold higher in tumors than in unaffected tissues of turtles with
fibropapillomatosis (Lu, et al. 2000a; Quackenbush, et al. 2001). In situ hybridization localized
herpesviral DNA to the nuclei of clusters of acanthotic epithelial cells of tumors, and mRNA
transcripts to the nuclei of clusters of epithelial cells of sea turtles from Puerto Rico (Kang, et al.
2008). More recently, herpesvirus-like particles were also found by TEM in areas of ballooning
degeneration with eosinophilic epidermal intranuclear inclusions (EIIs), indicating viral
replication in the epidermal cells of tumors (Work, et al. 2014). These collective data provide
strong evidence that ChHV5 is the causative agent of FP.

Without an established culture system, molecular biology methods are the best way to study the
role of ChHV5 in the development, progression, and regression of FP. Currently, 132,233 base

pairs of ChHV5 DNA have been sequenced from the glottis tumor of a Hawaiian green sea turtle
(Ackermann, et al. 2012). Multiple sequencing studies have suggested that ChHV5 is an
alphaherpesvirus (Ackermann, et al. 2012; Greenblatt, et al. 2005a; Herbst, et al. 2004; Nigro, et
al. 2004), determined by sequence homology, as well as its gene order and orientation. Previous
phylogenetic analyses have focused on short segments of the polymerase gene or concatenated
regions of multiple ChHV5 genes, revealing the existence of geographic ChHV5 variants (Ene,
et al. 2005; Greenblatt, et al. 2005a; Greenblatt, et al. 2005b; Herbst, et al. 2004). This has
provided insight into the evolution of these viruses, indicating that ChHV5 has co-evolved with
its sea turtle host over millions of years, and suggesting that environmental changes have likely
affected virus transmission and disease expression from an already established viral infection
(Ene, et al. 2005; Greenblatt, et al. 2005a; Herbst, et al. 2004). The geographically driven
genetic differences of ChHV5 is concordant with differences in disease manifestation by
location. For example, oral tumors are commonly found on Hawaiian turtles while they are
rarely found in Florida turtles (Aguirre, et al. 2002), analysis of EIIs using
immunohistochemistry revealed FP turtles from Florida, but not Hawaii, developed antibodies to
ChHV5 antigens (Herbst, et al. 1998), and unlike Florida, FP is declining in Hawaii (Chaloupka,
et al. 2009; Chaloupka, et al. 2008; Hirama and Ehrhart 2007).

Most of the genome information originates from Hawaiian sea turtles, highlighting the need for
virus genome information from Florida, especially given the geographic variability in ChHV5
genetics. However, the latent stage of ChHV5 has impeded the use of typical laboratory
methods used to prepare viral templates for sequencing, such as cell culture and virion
purification (Greenblatt, et al. 2004; Lu, et al. 1999; Work, et al. 2009). Attempts to isolate viral

particles (as described in appendices 1 and 2) and episomal DNA failed. Furthermore, relatively
low ChHV5 copy numbers compared to host DNA precludes sequencing the virus directly from
the tumor (Quackenbush, et al. 2001). The recently sequenced ChHV5 genome from the glottis
tumor of a Hawaiian green was completed by screening over 10,000 BAC clones (Ackermann, et
al. 2012), making this a fairly inefficient approach. However, sequencing the BAC clone has
provided a way to circumvent the methodological limitations of sequencing ChHV5 by providing
a template for LR-PCR. Next-generation sequencing of LR-PCR amplicons was used to
characterize the partial genome of ChHV5 from three different Florida sea turtle species,
including loggerhead (Caretta caretta), green (Chelonia mydas), and Kemp's ridley
(Lepidochelys kempii).

Methods
Tumor collection and DNA extraction
Tumors were collected from Florida loggerhead (n=2), Kemp’s ridley (n=2), and green (n=1) sea
turtles in accordance with MTP# 15-00223 (Table 1). Tumors were archived at -80°C. One
tumor from each sea turtle was dissected (>25mg) for DNA extraction using the DNeasy Blood
and Tissue Kit (Qiagen, Valencia, California).

PCR amplification and Illumina sequencing
PCR primers were designed to amplify ~5000 bp regions of the ChHV5 genome using the
Hawaiian green sea turtle ChHV5 genome as a reference genome (Table 2). Long range
polymerase chain reactions (LR-PCR) were performed using the TaKaRa LA polymerase kit
(ClonTech, Palo Alto, California), which is optimized for longer amplicons. The standard

protocol containing 0.2 µM of each primer, 200 µM of dNTPs, 1.25 U/50 µl of PrimeSTAR
GXL buffer, 1.25 U/50 µl of PrimeSTAR GXL DNA Polymerase, and 2.5 µl of DNA template in a
25 µl reaction was performed on all samples as follows: 93°C for 3 min, followed by 30 cycles
of [98°C for 10 seconds, 60°C for 15 seconds, and 68°C for 5 minutes]. If the standard protocol
was unsuccessful, the reaction was optimized according to the manufacturer’s troubleshooting
manual. LR-PCR products were verified by gel electrophoresis and cleaned using the DNA
Clean and Concentrator™ kit (Zymo, Irvine, California). If there was non-specific primer
binding resulting in multiple bands, the band of the expected size band was purified directly from
the gel using the UltraClean® GelSpin® DNA extraction kit (MoBio, Carlsbad, California).
Cleaned amplicons were quantified using the Qubit dsDNA HS assay kit on a Qubit 2.0
Fluorometer (Thermo Fisher Scientific, Waltham, Massachusetts) and normalized to 1 ng/µl
using sterile water. Samples were pooled and libraries were prepped using the Nextera XT DNA
Library Prep Kit according to the manufacturer’s manual following suggested modification for
larger insert size (Illumina, San Diego, California). Libraries were validated for size using the
Agilent BioAnalyzer High Sensitivity DNA Kit (Agilent Technologies, Palo Alto, California),
quantified using the Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Invitrogen,
Carlsbad, California) and normalized to 4 nM using 10 mM Tris, pH 8.5. The pooled libraries
were run at 15 pM with a 5% PhiX174 spike on the Illumina MiSeq with a 600 cycle v3 reagent
kit (Illumina, San Diego, California).

Data analysis
Machine demultiplexed fastq files were trimmed and imported onto BaseSpace. Reads were
checked for quality using FastQC. Geneious v. 7.0 was used to assemble reads to the ChHV5

genome sequence (accession HQ878327) and to generate consensus sequences. For each
sample, consensus sequences were aligned using Geneious. A Region of the capsid gene with
full coverage for all samples were removed and aligned using MUSCLE. This 4,152 bp region
of the capsid gene was compared against the GenBank non-redundant database using BLASTn.
ChHV5 sequences with 100% query coverage were included into the alignment for phylogenetic
analysis. Maximum-Likelihood trees were created in MEGA with bootstrap replicates of 1000
(Tamura, et al. 2007).

Results
The primer success rates were different for each sample, resulting in different coverage of the
reference genome for each sample (n=5) (Fig. 1). The loggerhead consensus sequences covered
89.5% and 83.4 % of the reference genome, while the Kemp’s ridley consensus sequences had
87.9% and 45.7% coverage (Table 1). The low coverage Kemp’s ridley consensus sequence
(Kemp’s ridley 2) was excluded from the phylogenetic analysis. The repeat sections of each
ChHV5 genome are missing due to low primer success rates and sequencing difficulties.
Phylogenetic analysis of a 4,152 bp region of the capsid gene region shows that two of the clades
group by location, and one clade groups by species (Fig. 2A). A pairwise identity analysis is
concordant with the phylogenetic tree, with the green sea turtles form HI (AF035003.3 and
AY644454.1) being the most divergent from the other samples (Fig. 2B). Although the
loggerhead (#2) sea turtle is in a clade by itself it is 96-100% identical to the other samples.

Discussion

The incidence of fibropapillomatosis among Florida’s sea turtles has increased significantly over
the past two decades (Herbst 1994; Hirama and Ehrhart 1999; Hirama and Ehrhart 2007) and has
significantly contributed to stranding events of Florida sea turtles. Although fibropapillomatosis
is a threat to sea turtle populations, the development and progression of FP is not understood,
partially due to the technical difficulties of researching this virus. There are currently 125 partial
ChHV5 sequences on NCBI, ranging from 181-22,947 bp, with only one genome. The lack of
sequence data makes it difficult to understand ChHV5 evolution, thereby impeding our
understanding of the contribution of ChHV5 genetics to disease development and regression.

Long-range PCR paired with next-generation sequencing has proven useful for characterizing the
majority of the ChHV5 genome, but large gaps still remain. The high GC content, large genome
size and the repetitive nature of the genome create PCR difficulties. The large genome size also
makes PCR amplicon sequencing inefficient for large sample sizes, especially with the primers
not working for all samples. It is also a possibility that sequence regions that did not amplify
using the primers designed from the reference genome are divergent. Furthermore, even if the
PCR was successful, sequencing depth is also decreased in cases of high GC content and
repetitive sequences (Jia, et al. 2014).

Previous phylogenetic analyses focusing on specific genes or concatenated regions of genes such
as the DNA polymerase gene and glycoprotein B gene have revealed the existence of geographic
ChHV5 variants by (Ene, et al. 2005; Greenblatt, et al. 2005a; Greenblatt, et al. 2005b; Herbst, et
al. 2004; Patrício, et al. 2012). These phylogenetic analyses have proven to be informative and
have provided clues to how ChHV5 has spread. However, the new phylogenetic analysis of part

of the capsid region performed here, is different from the previous analyses that have shown
ChHV5 to clade by location. The topology of the capsid tree shows clades based on species, as
well as location. While evolutionary relationships are typically based on comparisons of a subset
of genes, this may not be the best way to capture ChHV5 evolution, since phylogenetic trees
comparing different genes may result in different topology, as shown here (Nei 1987; Zimmerer
1991). Phylogenetic analysis of a specific gene, or a subset of genes, is informative for
understanding gene evolution, but to elucidate the evolutionary history of ChHV5, genome-wide
comparisons are necessary. Unlike gene comparisons, genome-wide comparisons can detect
lateral gene transfer, transposons, and recombination events.

In the available ChHV5 genome, repeat sections contain genes homologous to human latency
modulating genes, including ICP0, ICP4, and the latency-associated nuclear antigen (LANA)
(Ackermann, et al. 2012). In the human Kaposi’s sarcoma herpesvirus (KSHV), the LANA also
inhibits the host tumor suppressor gene p53, preventing apoptosis and thereby allowing for the
development of tumors (Friborg, et al. 1999). Therefore, despite the sequence difficulties
associated with the repeat sections, they contain important genetic information and should not be
ignored. Additionally, the identification of ChHV5 oncogenes, as well as genes that are involved
in modulating latency may have important implications for management and treatment of FP.

Ongoing studies are focusing on characterizing the genome of ChHV5 using target enrichment to
capture ChHV5 DNA directly from tumor tissue, paired with PacBio, which provides long reads
that can be assembled back to the reference genome (Rhoads and Au 2015). The newly
sequenced genomes can then be used to create an updated phylogeny comparing ChHV5 across

multiple locations and species, evaluating the selective pressure on each gene and providing
insight into the role genetics plays in the manifestation of FP.
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Figures

Figure 1. Current coverage of the reference genome by LR-PCR and Illumina sequencing of
ChHV5 from Florida green, loggerhead, and Kemp’s ridley sea turtles.

Figure 2. (A) Maximum-Likelihood phylogenetic tree inferred from a MUSCLE alignment of a
4,152 nt region of the capsid gene. (B) Pairwise-identities of the of the same region of the capsid
gene.

Species
Loggerhead (1)
Loggerhead (2)
Kemp's ridley (1)
Kemp's ridley (2)
Green

Collected by
Mote
UGA
FWC
FWC
Mote

Table 1. Sample summary.

Collection date
3/1/2008
unknown
1/17/2015
10/7/2014
8/16/2007

Coverage (%)
89.5
83.4
87.9
45.7
68.2

Table 2. Primer sequences and amplification success in each sample.
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New diseases in marine animals are emerging at an increasing rate, yet methodological limitations hinder
characterization of viral infections. Viral metagenomics is an effective method for identifying novel viruses
in diseased animals; however, determining virus pathogenesis remains a challenge. A novel anellovirus
(Zalophus californianus anellovirus, ZcAV) was recently reported in the lungs of captive California sea lions
involved in a mortality event. ZcAV was not detected by PCR in the blood of these animals, creating the
inability to assess the prevalence of ZcAV in live sea lions. This study developed an enzyme-linked
immunosorbent assay (ELISA) to detect antibodies to ZcAV in sea lion serum. To assess ZcAV prevalence,
paired serum and lung samples (n 5 96) from wild sea lions that stranded along the California coast were
tested through ELISA and PCR, respectively. Over 50% of the samples tested positive for ZcAV by ELISA
(34%), PCR (29%), or both (11%) assays. ZcAV is prevalent in stranded wild sea lion populations and results
suggest that PCR assays alone may grossly underestimate ZcAV exposure. This ELISA provides a tool for
testing live sea lions for ZcAV exposure and is valuable for subsequent studies evaluating the potential
pathogenicity of this anellovirus.

T

he rate of emergence of new diseases in marine animals is increasing1–4, generating a need for surveillance of
potential pathogens to protect marine mammals against epidemics. However, it remains difficult to characterize and diagnose viral infections because of methodological limitations5. Current detection methods
such as degenerate PCR and pan-viral microarrays can detect close relatives of previously described viruses, but
are limited for detecting novel viruses. Viral metagenomics (virus particle purification followed by shotgun
sequencing) is an effective method for identifying viruses involved in mortality events in marine animals6–9,
yet it remains difficult to establish a connection between a novel virus and disease due to limitations of culturing
the viruses as well as difficulties in obtaining fresh diagnostic tissues from wild marine mammals.
Viral metagenomics performed on lung tissue of several necropsied captive California sea lions (Zalophus
californianus) with signs of respiratory disease that were involved in a mortality event of unknown cause revealed
the presence of a novel anellovirus, Zalophus californianus anellovirus (ZcAV)7. ZcAV was found by specific PCR
in the lungs of all three of the sea lions that died in the mortality event, but it was not found in sea lions from the
same zoo that died of unrelated causes. In addition, ZcAV was found to be actively replicating in lung tissue of a
sea lion from the mortality event, further suggesting an association of ZcAV with the death of these animals. In
addition to the captive sea lions, 11% of lung samples from wild sea lions stranded off the California coast tested
positive for ZcAV by PCR, indicating that this anellovirus is present in wild populations.
The initial ZcAV discovery and prevalence studies have raised many questions about the potential pathogenicity of this virus. Anelloviruses have been extensively studied in humans, where these viruses can be highly
prevalent (infecting up to 100% of the population)10–13, yet they have not been linked to human disease. Although
anelloviruses have also been found in a wide range of mammals including non-human primates14, domestic
animals15, Pacific harbor seals9, and Risso’s dolphins (E.M. Fahsbender et al., unpublished data), anellovirusassociated pathology remains unknown. Initial evidence suggested that ZcAV may be linked to the mortality
event of captive California sea lions; however, studies investigating the pathogenicity of this virus are difficult
since ZcAV has only been detected by PCR in tissues of necropsied animals, and cannot be detected by PCR in the
blood of infected individuals7. The inability to detect ZcAV in blood samples by PCR severely limits further
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testing for this virus, since obtaining lung biopsies from live sea lions
is not possible. Hence, there is a critical need for an assay to detect
ZcAV exposure in blood samples to investigate the epidemiology of
this virus, understand its association with disease, and preemptively
develop management strategies that can prevent the spread of this
virus in captive and rehabilitation animals. To overcome these technical limitations of studying the role of ZcAV in disease, here we
describe the development of an enzyme-linked immunosorbent
assay (ELISA) for ZcAV, and demonstrate that sea lions mount an
immune response against ZcAV.
Similar to other anelloviruses16, ZcAV contains a small (2140 nucleotide (nt)), negative sense, single-stranded DNA circular genome
that encodes three major open reading frames (ORFs). Based on
similarities to other anelloviruses, ORF 1 is believed to encode the
capsid protein, although this has not been experimentally demonstrated for any anellovirus. For other anelloviruses, the ORF 1 gene
product has been predicted to be antigenic due to the presence of
major hydrophilic regions, and ORF 1 has been successfully used in
seroprevalence studies in humans and pigs11,17–20. Here we developed
an ELISA based on hydrophilic regions of the ORF 1 gene product of
the ZcAV genome and demonstrated that this assay is capable of
detecting anti-ZcAV antibodies in sea lion serum. This ELISA provides a tool for studying ZcAV epidemiology and identifying seroconversion upon symptom development in captive sea lions,
enabling future research investigating the pathogenesis of ZcAV.
Finally, the creation of this assay lays the groundwork for bridging
the gap between genome discovery via viral metagenomics and assessing the epidemiology of novel viruses and their significance for wild
populations.

Methods
Sample collection. Paired serum and lung samples were collected from 100
California sea lions involved in stranding events along the coast of northern
California. All samples were collected by The Marine Mammal Center located in
Sausalito, California in accordance with Marine Mammal Protection Act permit no
932-1905/MA-009526 to Gulland. Serum samples were collected during routine
clinical examinations of live stranded sea lions as described by Bossart et al.21 and
archived at 270uC. Lung samples were collected from the same animals upon
necropsy, with animals stored at 4uC between time of death and necropsy (within
24 hours of death). All protocols were approved under the Marine Mammal
Protection Act. Paired lung and serum samples were shipped to the University of
South Florida and stored at 280uC for processing using PCR (for lung samples) and
ELISA (for serum samples).
PCR testing of sea lion lung samples. Lung samples were tested with a ZcAV-specific
PCR assay. For this purpose, DNA was extracted from approximately 25 mg of sea
lion lung tissue using the DNeasy Blood and Tissue Kit (Qiagen). DNA was amplified
through rolling circle amplification (RCA) using the Illustra Templiphi Kit (GE
Healthcare), which is known to enrich for small circular templates such as the ZcAV
genome22,23. RCA products were then used as the DNA templates for the PCR assay
using primers ZcAV1056F (59-AGG CAC TCA CAT AAT CTA TTC AA-39) and
ZcAV1369R (59-CCC AGG CAT TAC AGG CTT TA-39) designed to target a 314 nt
region from ORF 1 of ZcAV. The PCR [containing 1 mM of each primer, 200 mM of
dNTPs, 1 U of Red Taq (Sigma-Aldrich), 1X Red Taq reaction buffer and 2.5 ml of
DNA template in a 25 ml reaction] proceeded as follows: 95uC for 5 minutes, 45 cycles
of [94uC for 1 minute, 54uC for 1 minute, and 72uC for 1 minute], followed by a final
extension at 72uC for 10 minutes. PCR products of the correct size were verified by gel
electrophoresis. Four samples were cloned using a TOPO TA Cloning Kit
(Invitrogen) and commercially sequenced. Sequences were then compared against
the GenBank database in order to verify the specificity of the assay. To determine
assay sensitivity, a positive control was prepared as previously described. The PCR
product was cleaned using the UltraClean PCR Clean-Up Kit (Mo Bio Laboratories)
and quantified using a NanoDrop ND-1000 apparatus (NanoDrop Technologies).
The number of targets per microliter was back-calculated and the positive control was
serially diluted to determine the sensitivity of the assay, which was 10 targets.
Optimization of ELISA parameters. An ELISA was developed to screen sea lion
serum for antibodies to ZcAV. Since the virus was identified from a mixed
community using metagenomics, there were no purified virus particles that could be
used as an antigen for the ELISA. Therefore, the ELISA was developed based on
regions predicted to be immunogenic based on hydrophilic sections found in the
predicted protein sequence of ORF 1. Four peptides (on average, 25 amino acids in
length) from different regions of ORF 1 were synthesized at 70% purity by Pacific
Immunology. Each of these peptides was scrambled, synthesized and used as a control
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peptide. Sea lion sera were used as primary antibodies, while alkaline phosphatase
(AP)-conjugates of protein A (Roche) and protein L (Thermo Scientific) were used as
detection reagents. Protein A is a bacterially-derived molecule that binds to the Fc
region of IgG of many mammalian species; in contrast, protein L, also derived from
bacteria, binds to immunoglobulin light chains and thus has the ability to detect a
wider range of serum antibodies, including IgG, IgM, IgA and IgE24–26. Similar
reagents have been used previously in sea lion serological testing26. Checkerboard
titrations were performed to find optimal concentrations of peptide, serum, and
proteins. After initial screening, peptide 4T (amino acid sequence:
GMENTPPKRVRFRQSDVLRKHKHRI), along with its scrambled control peptide
4C (amino acid sequence: QRLHPKKHIRSETKFVRVDRNPGMR) were chosen as
primary targets due to their low background. Protein L was selected as the detection
reagent since it is able to bind more classes of immunoglobulins than protein A.
ELISA testing of sea lion serum samples. High binding 96-well microtiter plate wells
were coated with a final concentration of 1 mg/ml peptide diluted in 0.5 M carbonate
buffer (pH 9.6) (1.59 g of Na2CO3, 2.93 g of NaHCO3, 0.2 g of NaN3, and dH2O to 1
liter) and the plate was incubated overnight at 4uC. All wells were washed three times
with a phosphate-buffered saline (PBS) solution containing 0.1% Tween-20 (PBStween) using an automated microtiter plate washer, and then blocked with 1% bovine
serum albumin (BSA) diluted 155 in PBS-tween for 1 hour. Sea lion serum samples
were diluted 1550 in PBS-tween containing 1% BSA, added to each well in triplicates,
and left to incubate overnight at 4uC. The plate was then washed and blocked as
previously described before secondary reagent protein L was added in PBS-tween
containing 1% BSA at a 1510,000 dilution and left to incubate at 37uC for 1 hour.
Each well was washed as previously described. ELISA Blue (SureBlue Reserve) was
added and incubated at room temperature for 10–20 minutes. Plates were read on a
PerkinElmer Enspire machine to measure optical density (OD) at 650 nm.
Statistical Analysis. The statistical software package GraphPad Instat (GraphPad
Software, Inc.) was used to perform an analysis of variance (ANOVA) on averages of
the triplicate sea lion serum samples. Samples with p-values ,0.05 were considered
statistically significant. Samples were considered positive if serum incubated with the
test peptide (4T) had a statistically significant higher OD value than the serum
incubated with the control peptide (4C).

Results
Development of the ELISA using serum samples from sea lions
whose lung samples were PCR-positive for ZcAV demonstrated that
sea lions mount an immune response to ZcAV infection. Paired
serum and lung samples from 100 stranded California sea lions were
then tested for the presence of ZcAV nucleic acids and anti-ZcAV
antibodies through PCR and the newly developed ELISA, respectively. Four samples were removed from the data set due to high
background with the ELISA. Of the 96 samples tested, 50 (52%)
tested positive for ZcAV exposure (ELISA; serum samples; n533
[34%]) and/or DNA presence (PCR; lung samples; n528 [29%])
(Table 1). Eleven percent of the sea lions tested positive for ZcAV
by both ELISA and PCR, and 48% of sea lions tested negative by both
methods. Of the 28 sea lions with PCR-positive lung samples, 39%
were also serum-positive by ELISA. However, 32% of the PCR-negative sea lions (n568) also tested positive for ZcAV exposure via
ELISA. The Kappa value of 0.066, calculated using GraphPad, indicates poor correlation between the PCR and ELISA test results.
Discussion
The ELISA developed in this study provides the first and only
method to test for ZcAV exposure in live sea lions. Here, this assay
was used in combination with PCR to assess the prevalence of ZcAV
in the wild, stranded sea lion population along the northern coast of
California. Protein-L-based detection of ZcAV-specific antibodies
suggests the exposed sea lions are able to recognize and mount
immune responses to the virus. These data, which are the first
obtained for marine mammal anelloviruses, support prior studies
showing that human anelloviruses are immunogenic, with both
IgG and IgM class antibodies produced upon exposure to ORF
127,28. The combined ELISA and PCR results demonstrate that
ZcAV infections are prevalent and persistent in wild California sea
lions.
The development of this ELISA was unconventional due to the
many difficulties of working with marine mammals. Gaining access
to 100 paired serum and lung samples from a protected species is
both arduous and time consuming. Furthermore, the sea lion
2
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Table 1 | Prevalence of ZcAV in paired serum and lung samples from a stranded wild population of California sea lions (Zalophus
californianus; n596) assessed by ELISA and PCR, respectively

Lung PCR positive n5 (%)
Lung PCR negative n5 (%)
ELISA totals n5 (%)

Serum ELISA positive n5 (%)

Serum ELISA negative n5 (%)

PCR totals n5 (%)

11 (11%)
22 (23%)
33 (34%)

17 (18%)
46 (48%)
63 (66%)

28 (29%)
68 (71%)

immune system is not frequently studied; therefore, there are no
commercial antibodies for sea lions. In addition to the many ambiguities of the sea lion immune system, ZcAV is not a well-understood
virus. ZcAV was discovered from a mixed community and attempts
to isolate ZcAV virions in culture have been unsuccessful, limiting
sensitivity testing of this ELISA. In addition, without more knowledge of the types of related anelloviruses found in marine mammals,
the specificity of this assay cannot be determined.
Although the ELISA and PCR results obtained in this study were
not correlated, the ZcAV ELISA provides complementary results to
the PCR data, providing a greater scope to measure virus prevalence,
as use of the ZcAV ELISA increased the detection of exposure to
ZcAV. There are multiple explanations for the incongruences
between the ELISA and PCR data. ELISA-positive, but PCR-negative
samples (23%) are likely due to previous ZcAV infections in which
the viral DNA is no longer present but the ELISA can detect the
presence of (long-lived) antibodies, suggesting a prior exposure.
Similar results have been seen for the human anellovirus Torque
teno virus (TTV), where antibodies were detected despite the absence
of TTV DNA11. In addition, if the ZcAV infection occurred in
another sea lion organ instead of the lungs, we could expect a
PCR-negative but ELISA-positive result. Conversely, sea lion samples may have tested positive by PCR but negative by ELISA (18%) if
the sea lions were actively infected upon stranding and died before a
detectable antibody response was mounted. Although the timing of
the response of the sea lion immune system to ZcAV is unknown,
development of the human antibody response to TTV is slow and
known to take up to 21 weeks after virus inoculation29, although once
the antibodies are produced they persist in serum for long
periods28,30. Finally, slight sequence mutations or antigenic diversity
of anelloviruses may also contribute to data incongruency.
Anelloviruses are known to demonstrate a high degree of genetic
variability19,31,32 which can pose problems for both DNA detection
by PCR primers and antibody detection. For certain TTV genotypes,
it has been shown that multiple serotypes may exist in circulation20.
Future work should compare the diversity of anelloviruses that can
be detected by the PCR and ELISA utilized in this study, as the
discrepancy between the two assay types may reflect differences in
the diversity of genotypes and serotypes recovered.
Through a combination of PCR- and ELISA-based testing, this
study demonstrated that sea lions mount an immune response to the
anellovirus ZcAV and revealed the high prevalence of ZcAV in a
stranded wild sea lion population. The ELISA created here will enable
future research on the epidemiology of ZcAV in live sea lions and
allow further study of ZcAV pathogenesis by measuring seroconversion in infected captive sea lions. Finally, this assay has direct implications for protecting sea lion health since it is the only method
available for the detection of ZcAV in live sea lions. The ZcAV
ELISA enables the screening of rehabilitation animals before admitting them into facilities with healthy animals, which can prevent the
spread of this virus to other captive sea lions and provide a valuable
management step if further work links ZcAV with disease.
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